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ABSTRACT
The aim of this work was to investigate possible role of PKC in control of 
excitation-contraction coupling in phasic guinea pig and rat ureter smooth muscle. 
Immunohistochemistry and western blotting were used to identify the expression of 
four PKC isoforms a, p, 5 and e in ureter smooth muscle of both species. Photometric 
system combined with force measurement and electrical activity as well as confocal 
imaging of isolated ureteric myocites have been used in the functional studies. The 
effects of PKC activator PDBu and PKC inhibitor Ro320432 on force and Ca2+ 
induced by different modes of stimulation of ureter smooth muscle have been 
examined. It is established that expression and functional effects of PKC activation 
and inhibition in ureter smooth muscle were species dependent. Guinea pig ureter 
smooth muscle expressed predominantly PKC p and 8 while rat ureter showed the 
presence of one isoform PKC a. Direct activation of PKC by PDBu produced an 
increase in the amplitude of force which in the guinea pig ureter was associated with 
an increase in the duration of the Ca2+ transient. These changes in Ca2+ and force were 
associated with an increase in the duration of the plateau component of the action 
potential. The data obtained suggest that the prolongation of the plateau component of 
the action potential by PDBU in the guinea pig ureter smooth muscle was not 
associated with inhibition of Ca2+ sparks/STOCs coupling mechanism or modulation 
of the activity of the Na+-Ca2+ exchanger but is likely to be produced by stimulation 
of the Ca“ inward current via L-type Ca2+ channels. In the rat ureter smooth muscle 
an increase in the amplitude of force was totally Ca2+-independent and was associated 
with sensitization of the contractile machinery to Ca2+ via inhibition of MLCP activity. 
In both guinea pig and rat ureter PKC is partly but not fully responsible for the 
stimulant action of agonists.
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Chapter 1 
Introduction
1 Physiology and morphology of the ureter
1.1 Structure and function of the ureter
The ureter is a fibro-muscular tube connecting the bladder and kidney and is 
responsible for the transportation of urine from the kidney to the urinary bladder. 
Generally, the ureter helps to maintain kidney function by keeping the hydrostatic 
pressure of the renal collecting system low.
There are two ureters connecting with two kidneys in the body (Figure 1.1). Each 
ureter originates at the renal pelvis of the kidney, and terminates at the ureterovesical 
junction. This junction prevents retrograde urine reflux from the bladder into the 
ureter. The activity of ureteric smooth muscle is myogenic. Therefore, its contraction 
is not initiated by nerve stimulation or hormone regulation but by itself. The influence 
of the autonomic nervous system is secondary to the myogenic function and it 
contributes to the modulation of contractile activity. The ureter from most of the 
mammalian animals displays spontaneous contractile activity in vitro if the 
pelviureteral junction is kept intact (Exintaris et al., 1999). Some studies carried out 
on human ureter in vitro suggest that spontaneous activity has neural and hormonal 
input (Cole et al., 1988; Hua et al., 1987; Exintaris et al., 1999).
The ureter is a fibro-muscular tube consisting of a lining of urothelium, a layer of
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connective tissue outside the smooth muscle cells which are arranged into 
interconnecting muscle bundles. These bundles have different thickness and 
orientation so that excitation can pass along the muscle networking without the need 
for nerves (Figure 1.2). The individual smooth muscle fibers are 5 pm wide and 100 
-150pm long. The smooth muscle bundles spread differently along the different 
portions of the ureter (Tachibana et al., 1985). In the proximal and distal renal pelvis 
the arrangement of ureteric smooth muscle cell is loosely packed (Klemm et al., 1999). 
In the middle portion of ureter, the smooth muscle bundles are randomly oriented in 
an irregular manner. In the lower portion of the ureter, the bundles are longitudinal 
oriented (Tachibana et a l, 1985).
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Figure 1.1 Overview of urinary system. Two ureters connecting kidneys and bladder.
(Figure modified from www.biologycomer.com/.../raturogenital.htm l).
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Figure 1.2 Cross section of human ureter showing ureteric morphology. (Figure
modified from www.technion.ac.il/~mdcourse/274203/lectl4.html).
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1.2 Peristalsis of the ureter
The ureter propels urine in a peristaltic manner. Peristalsis of the ureter is autonomous 
and can be activated by stretch induced by increased urine volume. The peristaltic 
activity, which is controlled by a propagating action potential, originates from 
pacemaker cells at the proximal portion of the renal pelvis. Ureteric smooth muscle 
cells are normally quiescent and do not generate peristaltic activity unless being 
signaled by pacemaker cells. The action potential discharged from multiple 
pacemaker cells summates to trigger a wave of electrical activity which passes distally 
along the smooth muscle cells into the main ureter and gives rise to the mechanical 
event of peristalsis. This mechanism allows the ureter to propel a bolus of urine from 
kidney to the urinary bladder. Normal peristaltic activity of ureter smooth muscle 
could be disrupted by deficiencies in conduction of the coordinated contraction wave. 
It can be caused by inflammation and some other pathological problems like ureteric 
obstruction and reflux. Medical problems of the ureter also include ureteric stone, 
urethritis, cancer, and ureterocele.
1.3 Ureteric cells
Smooth muscle cells are the main functional unit of the ureter. So far, three types of 
cells that have been identified in ureter on the basis of their morphological and 
functional characteristics. They are termed atypical smooth muscle cells, typical 
smooth muscle cells and ICC-like interstitial cells.
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1.3.1 Pacemaker cells and their activity
It has long been accepted that myogenic contractile activity arises from the 
electrically active atypical smooth muscle cells localized in the proximal regions of 
the upper urinary tract. This region has similar properties to the smo-atnal node of the 
mammalian heart which is characterized by irregular cell shapes and contents 
(Gosling & Dixon, 1972; Lang e, al., 2006, 2007 (1)). The atypical smooth muscle 
cells generate a simple pacemaker action potential which appears as a single plateau 
type action potential (Klemm et al., 1999).
The distribution of atypical smooth muscle cells has been identified. They are located 
mostly at the renal pelvis of the mammalian ureter and their distribution decreases 
with distance from the proximal region and is nearly absent in the region of 
ureteropelvic junction (UPJ) (Lang et al.,1998, 2001). More than 80% of the smooth 
muscle cells in the pelvi-ealyceal junction (PCI) and 15% of the smooth muscle cells 
in the proximal renal pelvis were atypical smooth muscle cells. No atypical smooth 
muscle cells were found in the ureter proper and distal regions of the renal pelvis 
(Klemm el al., 1999). This is consistent with the distribution of action potentials 
recorded from pacemaker cells along the PCI, the proximal renal pelvis, the distal 
renal pelvis and the ureter. In addition, the decreased distribution of atypical smooth 
muscle cells along the renal pelvis compared to the UPJ is consistent with the 
myogenic activity found in renal pelvis but absent from the end of ureter (Lang et 
2002). Furthermore, an ureteropelvic junction, dissected free of ureter can maintain its
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myogenic activity producing spontaneous contractile activity (Lang and Zhang, 1996). 
Above all, this suggests that atypical cells exert pacemaker cell activity. In rat, it has 
been shown that the atypical smooth muscle cells can directly drive typical smooth 
muscle cells (Lang et al., 2002).
Atypical smooth muscle cells are short spindle-shaped and form a thin layer of loosely 
arranged cells (Gosling & Dixon, 1974). Their shapes and cell contents differ from the 
typical smooth muscle cells. Atypical smooth muscle cells have smaller nucleus lack 
non-specific cholinesterases (Gosling & Dixon, 1972, 1974; Klemm et al., 1999).
1.3.2 Other smooth muscle cells
Recently, it has been suggested that, in addition to atypical smooth muscle cells, 
ICC-like cells also play the role of pacemaker cells, but secondary to the role of 
atypical smooth muscle cells, and display spontaneous electrical activity (Lang et al., 
2006). ICC-like cells identified in the renal pelvis and the pelvi-calyceal junction 
display many characteristics which relate them to classical interstitial cells of Cajal 
(ICC) originally found in the intestine. Furthermore, they perform numerous 
communicating interconnections with other smooth muscle cells (Bums et al., 1997). 
ICC-like cells were oval-shaped and have a nucleus about 3-5 pm wide. ICC-like cells 
generate an intermediate action potential consisting of a single spike and a 
non-oscillatory plateau component.
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Typical smooth muscle cells are the predominant cells in the main ureter. The smooth 
muscle cells are tightly arranged into bundles and create a compact layer of muscle 
wall (Klemm et al., 1999). The action potential recorded from the typical ureter 
smooth muscle cell is a driven action potential which consists of an initial spike 
component followed by an oscillatory plateau component (Shuba, 1977(2); Klemm et 
al., 1999).
9
2 Mechanism of excitation-contraction coupling
In ureteric smooth muscle cells, the elevation of intracellular Ca concentration 
([Ca2+]i) is the main trigger for contraction. An increase in [Ca2+]j is either due to Ca2+ 
influx into the cell during depolarization or Ca2+ release from SR. Ca2+ entry into the 
cell is the main mechanism for the increased intracellular Ca2+ concentration in 
ureteric smooth muscle during the generation of the action potential (Sui et al., 1997). 
It has been found that in ureter smooth muscle Ca2+ influx into the cells is mediated 
not only by the voltage-dependent L-type Ca2+ channel, but also on the Na+-Ca2+ 
exchanger in “Ca2+ entry” mode (Aickin et al., 1984).
2.1 The role of the action potential in ureteric smooth muscle
The action potential produced in ureteric smooth muscle consists of a series of spikes 
followed by a prolonged plateau component lasting hundreds of milliseconds with 
oscillations of potential and a rapid declining repolarization phase terminated by an 
after-hyperpolarization (Figure 1.3). The major ionic currents underlying the action 
potential in the guinea pig ureter smooth muscle are Ca2+ inward current through 
voltage-activated L-type Ca2+ channels and Ca2+-activated K+ current which is the 
main outward current. 4-AP sensitive transient K+ current is also present.
The action potential recorded from single cells is similar to that seen in the 
multicellular preparation (Imaizumi et al., 1989). Under voltage clamp conditions, 
with KC1 in the pipette solution, depolarization steps from a holding potential of
10
-60mV to OmV triggers a complex ionic current consisting of transient inward Ca 
current followed by oscillatory K+ outward current (Lang, 1989).
The action potential can not be abolished by neurotoxins such as terodotoxin and 
capsaicin, which suggests that the generation and propagation of the action potential is 
myogenic (Washizu, 1966; Maggi et al., 1995). However, the action potential can be 
abolished by Ca2+ channel blockers nifedipine, Cd2+ and Co2+. There is an absolute 
requirement for Ca2+ to generate the action potential. In addition, the elimination of 
extracellular Na+ can also abolish the plateau component of the action potential 
(Kuriyama & Tomita, 1970; Shuba, 1977(2)). It has been suggested that Na+ entry via 
a voltage-dependant Na+ channel which is not sensitive to tetrodotoxin, is involved in 
generation of plateau component of the action potential (Shuba, 1977(2)). Na+ entry 
may be important for the maintenance of the plateau phase of the action potential. 
BKCa channels were reported to play a key role in control of the duration of the 
plateau component of the action potential (Imaizumi et al., 1989).
Initiation of the action potential is mainly due to the activation of L-type Ca2+ 
channels resulting in Ca2+ influx into the cell, which generates the Ca2+ inward current. 
The initial spike component observed is due to the rapid activation of Ca2+ channels. 
Elevation of the extracellular Ca2+ concentration increases the amplitude of the initial 
spike (Vereecken et al., 1975; Exintaris et al., 1999). After the initial depolarization, a 
steady state - plateau component follows, during which oscillations are observed. This
2+
l l
has been suggested to be due to the slow inactivation of the Ca2+ inward current and 
repetitive activation of the Ca2+-activated K+ current. A slowly inactivating inward 
Ca2+ current counteracts the activated transient outward K+ current to generate the 
long lasting plateau component of the action potential (Imaizumi et al., 1989). 
Subsequently, repolarization of the action potential is caused by gradual activation of 
K+ channels overcoming the inward Ca2+ current repolarizing the cell to the resting 
membrane potential (Imaizumi et al., 1989). Finally, smooth muscle cells can not be 
activated during the hyperpolarization phase. When the ureter was stimulated in vivo 
by electrical stimulation at a slower rate than that of spontaneous activity generated by 
pacemaker cells, the contractions are inconsistent. This irregular frequency is due to 
the fact that the electrical stimuli are applied during the refractory period of the 
spontaneous activity (Weiss et al., 2006). The 4-AP sensitive K+ current has been 
suggested to be involved in the hyperpolarization and refractory period (Exintaris et 
al., 1999). The Ca2+ sparks/ STOCs coupling mechanism was shown to play a leading 
role in the generation of the refractory period in guinea pig ureteric smooth muscle 
(Burdyga & Wray, 2005).
The action potentials of ureteric smooth muscle are species dependent. The above 
description is mainly based on the studies carried out on the guinea pig ureteric 
smooth muscle. In rat ureter, the action potential and the ionic currents underlying this 
mechanism are different. The action potential is characterized by an initial fast spike 
followed by a plateau component without oscillations on the plateau phase. Unlike
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guinea pig ureter smooth muscle, five ionic currents have been found that contribute
to the generation of the action potential in rat ureter- two inward currents; a 
Ca2+-activated Cl' current and a Ca2+ current; and three outward currents- a 
Ca2+-dependent K+ current, an A type Ca2+-independent K+ outward current and a 
delayed rectifier type K+ current (Smith et al., 2002). In human ureter, the action 
potential is similar to the action potential observed in rat ureter (Figure 1.4) (Santicioli 
& Maggi, 1998).
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Action potential
Figure 1.3 A representative action potential o f guinea pig ureter. The action potential
consists o f a series of spikes and a prolonged plateau component (Figure modified 
from Burdyga & Wray, 1999).
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Figure 1.4 Action potential and phasic contraction recorded from guinea pig, human
and rat ureter smooth muscle (Figure modified from Santicioli and Maggi, 1998).
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2.1.1 The Ca2+ currents
It has been widely accepted that an inward Ca2+ current via L-type Ca2+ channels is 
the major depolarizing current to initiate the action potential in smooth muscle 
(Bolton et al., 1985; Ganitkevich et al., 1986). Several characteristics of the inward 
Ca2+ current have been identified in ureteric smooth muscle. In both rat and guinea 
pig ureter, the Ca2+ current can be completely abolished by the Ca2+ channel blockers 
nifedipine and verapamil, which results in a decreased duration and amplitude of the 
action potential and eventually full abolition of the action potential.
In the guinea pig ureteric smooth muscle, the Ca2+ current is activated at potentials 
positive to -50 mV. Peak amplitude reaches between 0 and +10 mV (Lang, 1989; Sui, 
et al., 1997). The Ca2+ current is inactivated slowly and is suggested to account for the 
sustained membrane depolarization during the long duration action potential by 
opposing the outward current (Sui, et al., 1997). The activation of the L-type Ca2+ 
channel by BayK8644 enhances the inward Ca2+ current which leads to an increased 
outward current in guinea pig ureteric smooth muscle (Lang, 1989; Sui, et al., 1997).
2.1.2 K+ currents
Generally, there are three kinds of outward currents found in excitable ureteric smooth 
muscle cells that can be resolved using voltage-clamp and a various pharmacological 
tools. These include a K+ current activated by intracellular Ca2+ (IKCa), a voltage 
dependant but not Ca2+ dependent K+ current (It0) and a delayed rectifier type of K+ 
current (Ikt) (Smith et al., 2002).
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In guinea pig ureter smooth muscle, two types of outward potassium currents have 
been observed upon depolarization: The dominant K+ current (¡Kca) elicited by 
depolarization has a large conductance and is carried by Ca2+-activated K+ (BKca) 
channels. This K+ current is known to act as a repolarization current. This large K+ 
current is sensitive to TEA and can be eliminated by using Ca2+ channel blockers such 
as Cd2+, nifedipine and verapamil (Terada, 1987; Imaizumi et al., 1989). The other K+ 
current found in guinea pig ureter has small conductance (It0) which is not sensitive to 
TEA but can be abolished by 4-AP (Imaizumi et al., 1989). It0 has properties similar 
to A-type current (Ia) observed in other types of smooth muscle and neurons. It0 can be 
activated and inactivated by changes in voltage. At the resting membrane potential, Ito 
is inactivated; its activation dependents on the K+ gradient across the plasma 
membrane (Conor & Stevens, 1971; Adam et al., 1980; Lang, 1989). However, unlike 
Ikce, ko does not act as a repolarizing current in action potential. In guinea pig ureter, 
inhibition of It0 with 4-AP increased the frequency and duration of the action potential. 
It0 plays a role in the after-hyperpolarization, the refractory period and the generation 
of the spontaneous action potential (Shuba, 1981; Exintaris et al., 1999). It is 
suggested that It0 opposes Ica and may contribute to the rate of decay of the 
after-hyperpolarization (Imaizumi et al., 1989; Okabe et al., 1987; Beech & Bolton, 
1988; Leech & Meech, 1988).
In rat ureteric smooth muscle, in addition to the two K+ currents found in guinea pig
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ureter mentioned above, a delayed inward rectifier type K+ current (Ik,-) has also been 
observed (Smith et al., 2 0 0 2 ). IKr has been characterized well in many other excitable 
cells (Cooper et al., 1991; Von et al., 1996). In vascular smooth muscle cells, 
endothelin-1 and angiotensin II inhibit hcr by activating PKC and adenosine stimulates 
Ik,- by activating PKA (Park et al., 2008). In the rat ureter, Cd2+ abolishes the inward 
current, STOCs and tail current but Iki remains especially after application of 4-AP at 
the end of depolarization pulse (Smith et al., 2002).
2.2 Agonists and the action potential
By using the double sucrose-gap method, Shuba (1977 (1)) showed that agonists, such 
as adrenaline, noradrenaline, and histamine, increased the duration of the plateau 
component of the action potential which was accompanied by an increased duration 
and amplitude of force.
The agonists, such as noradrenaline or histamine can produce an increase in the 
intracellular Ca2+ concentration, either due to the release of Ca2+ from the intracellular 
store (SR) or the influx of Ca2+ from the extracellular space (Breemen et al., 1989; 
Albert, 2003). Histamine depolarizes the cell membrane by affecting the passive ionic 
permeability of the membrane, and this is accompanied by a decreased membrane 
resistance. However, this can not explain the increased duration of the plateau 
component of the action potential.
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It is suggested that the increased duration of the action potential by noradrenaline and 
histamine is due to the activation of Na+ permeability. Shuba concluded that there is 
an effect on the potential-dependent conductance of the slow Na+ channel which is 
responsible for the generation of the plateau component of the action potential (Shuba, 
1977(1)). However, it has not been possible to detect any inward Na+ current in 
ureteric smooth muscle until now. After blocking Ca2+ channels with a Ca2+ channel 
inhibitors such as nifedipine or elimination of extracellular Ca2+, no inward current is 
detected. Therefore, it is suggested that there is an intracellular Ca2+ concentration 
dependent inward Na+ current or an inward current entering via electrogenic Na+ -  
Ca2+ exchange (Imaizumi et al., 1989). Unfortunately, due to the limitations of the 
techniques used, the first possibility is unfit for examination.
2.3 Ion channels
2.3.1 The voltage-gated Ca2+ channel (VGCC)
The inward Ca2 current displays different characteristics and kinetics in different 
smooth muscles. This may be accounted for by the different Ca2+ channels expressed 
in smooth muscle. Generally, several VGCCs are expressed in smooth muscle and 
have been reported to function in different types of smooth muscles- L-type, T-type 
and N-type voltage-gated Ca2+ channels (Jensen et al., 2004; Salemme et al., 2007). 
In ureteric smooth muscle, electrophysiological, pharmacological and 
immunohistochemical studies suggest that L-type Ca2+ channels are responsible for 
generating of the action potential that mediates excitation-contraction coupling (Lang,
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1989; Imaizumi et al., 1989; Santicioli & Maggi, 1998).
Depolarization and activation of Ca2+ entry via L-type Ca2+ channels is a fundamental 
mechanism in the physiological activation of ureteric smooth muscle as Ca2+ channel 
blockers nifedipine and verapamil suppress the inward Ca2+ current, action potential 
and phasic contractions (Shuba, 1977(2), 1980; Exintaris et al., 1999; Lang et al., 
2006). It has been widely accepted that an inward Ca2+ current via L-type Ca2+ 
channel is the major depolarizing current to initiate action potential in smooth muscle 
(Bolton et al., 1985; Ganitkevich et al., 1986). At lower concentrations, nifedipine and 
verapamil can abolish the plateau component of the action potential, while a higher 
concentration of both drugs can completely abolish the generation of the action 
potential (Imaizumi et al., 1989; Lang et al., 1990; Smith et al., 2002). Several 
characteristics of Ca2+ inward current have been identified in ureteric smooth muscle. 
In both rat and guinea pig ureter, the Ca2+ current can be completely abolished by the 
Ca2+ channel blockers nifedipine and verapamil, which results in a decreased duration 
and amplitude of action potential and eventually abolishment of the action potential 
(Lang, 1990; Smith et al., 2002). High K+ solution can fire an action potential by 
activating L-type Ca2+ channels. After application of a Ca2+ channel blocker, both the 
phasic and the tonic components of a contraction induced by elevation of extracellular 
K+ concentration can be inhibited (Santicioli & Maggi, 1998; Sunano, 1976). Maggi 
et al. showed that PKA inhibitors can inhibit the tonic component of contraction 
induced by high K+. PKA may play an important role in the modulation of L-type
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Ca2+ channels and especially for the maintenance of the noninactivating state of the 
Ca2+ channels (Imaizumi et al., 1989; Maggi et al., 1996).
2.3.2 BKCa Channels
The BKCa channel is a large conductance voltage and intracellular Ca2+-dependent 
channel. It has a uniquely large channel current and so is termed BKca channel for its 
big K+ current. Under voltage clamp conditions, the current through the BKca channel 
appears as a spontaneous transient outward current (STOCs) first described by Bolton 
and Benham (Bolton & Benham, 1985).
The presence of STOCs in both guinea pig and rat ureteric smooth muscle cells has 
been demonstrated (Imiazumi et al., 1989; Lang, 1989; Smith et al., 2002; Borisoval 
et al., 2007). The BKca channel is normally activated by Ca2+ release from the SR in 
the form of Ca2+ sparks (Nelson et al., 1995; Burdyga & Wray, 2005). The activity of 
K+ outward current via BKca channel has been shown to have the same kinetics as 
Ca2+ sparks (Nelson et al., 1995; Bonev et al., 1997; Jaggar et al., 1998; Porter et al., 
1998). The activity of BKCa channels is increased by the increased Ca2+ spark activity 
caused by application of caffeine (Borisova et al., 2007). In vascular smooth muscle, 
it has been shown that activation of PKC inhibits BKca channel activity (Crozatier, 
2006; Ko et al., 2008). It has been suggested that in ureter smooth muscles BKca 
channels serve distinct physiological functions such as control of the refractory period, 
excitability and the duration of the action potential (Burdyga & Wray, 2005; Borisova
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e t  a l., 2007).
2.3.3 Other K+ channels
In addition to the BKCa channel, there are another two types of K+ channel have been 
identified in ureteric smooth muscle: the voltage-dependant K+ channel (Kv) and the 
delayed inward rectifier K+ channel (Kjr) (Smith et al., 2002).
The current through voltage-dependent K+ channel has been found in both rat and 
guinea pig ureteric smooth muscle. The current has properties similar to the A-type 
current originally found in molluscan neurons (Connor & Stevens, 1971; Adam et al., 
1980). At a resting membrane potential of about -60mV, this channel is inactivated. 
However, these channels can be activated if voltage clamped ureteric myocites are 
depolarized to -30mV from a holding potential o f-80 mV (Lang, 1989).
The delayed inward rectifier K+ channel has been found in rat ureteric smooth muscle 
cells but not the guinea pig. It is insensitive to TEA or Ca2’ (Smith et al., 2002). The 
delayed inward rectifier K+ channel activity has been suggested to account for little 
effect of TEA on the duration of the action potential in rat ureter which is in contrast 
to its marked effect on the duration of the action potential in the guinea pig ureter 
(Smith et al., 2002).
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2.3.4 Cica Channel
Clca channels have been identified in rat ureteric smooth muscle by Smith et al. 
(Smith et al., 2002). This channel is activated by Ca2+ and Cf efflux depolarizing the 
cell membrane which leads to opening of voltage-dependent Ca2+ channels and Ca2+ 
influx into the cells.
The Clca channel was first reported in amphibian tissue in rod segments from 
salamander retina. It has also been found in several smooth muscle tissues, vascular, 
airway, rat ureteric and uterine smooth muscle (Greenwood et al., 1996; Amaudeau et 
al., 1997; Smith et al., 2002). However, it is not present in all types of smooth muscle. 
For example, Clca channels are absent in guinea pig ureteric smooth muscle, which is 
thought to be one of the explanations for the species dependence mechanism of 
generation of the action potential in rat and guinea pig ureteric smooth muscle 
(Imaizumi et al., 1989; Lang et al., 1990).
Clca channels can be activated by excitatory neurotransmitters and other agonists. In 
the rat portal vein it was shown that noradrenaline can significantly increase Cf 
conductance and lead to membrane depolarization. Endothelin has been also shown to 
activate Icica in vascular smooth muscle. Histamine can also increase Clca channel 
activity in airway smooth muscle (Large & Wang, 1996). The removal of extracellular 
Ca2+ eliminates I cica suggesting that its activation is dependent on Ca2+ entry. In rat 
ureter, it is activated by Ca2+ influx via the L-type Ca2 channel (Smith et al., 2002).
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Activation of the Clca channel can also be induced by Ca2+ release from the SR 
(Amedee et al., 1990; Lamb et al., 1994).
Activation of Clca channels produces spontaneous transient inward currents (STICs).
STICs can be activated by local [Ca2+]i increase such as Ca2+ sparks or Ca2+ puffs due
2+
to the opening of both IP3 and RyR channels. Large Icica can also be activated by Ca 
waves (Mironneau et al., 1996; Haddock et al., 2002).
2.3.5 The Na+-Ca2+ exchanger
The existence of the Na+-Ca2+ exchanger in guinea pig ureteric smooth muscle has 
been demonstrated by Aickin, Brading and Burdyga (Aickin et al., 1984). These 
authors demonstrated that it can operate in Na+-loaded ureter. However, its function in 
ureteric excitation-contraction coupling remains to be demonstrated, although 
Aaronson and Benham showed the contribution of the Na+-Ca2+ exchanger to Ca2+ 
flux in voltage clamped ureteric myocytes (Aaronson and Benham, 1989).
The Na+-Ca2+ exchanger is electrogenic. Normally, it pumps out one Ca2+ ion in 
exchange for three Na+ ions therefore generating a net inward current. The Na+-Ca2+ 
exchanger is a reversible transporter and can operate in both “Ca2+ extrusion” or “Ca2+ 
entry” mode depending on the membrane potential and prevailing Na+ and Ca2+ 
gradients.
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So far, there is no specific Na+-Ca2+ exchanger inhibitor found. Several studies show 
that manganese (Aickin et ah, 1987), La3+(Weiss, 1974) and dodecylamine (Philipson 
et al., 1985) all inhibit Na+-Ca2+exchanger activity in guinea pig ureteric smooth 
muscle. However, all of them have an additional effect on L-type Ca2+ channels 
(Aickin et ah, 1987). The lack of a specific inhibitor for the Na+-Ca2+ exchanger 
accounts for the depth of studies into its contribution to the mechanism of smooth 
muscle contraction.
The Na+-Ca2+ exchanger is not the only mechanism responsible for the regulation of 
Ca2+ homeostasis in smooth muscle by transporting Ca2+ out of the cell. An 
ATP-dependent Ca2+ pump is also found to extrude Ca2+ out of the cells to maintain 
the low intracellular Ca2+ concentration (Floyd & Wray, 2007).
2.4 Refractory period
The refractory period is a period of inexcitability during which the excitable tissue 
fails to respond to any stimulus (absolute refractory period) or requires a greater 
stimulus to generate a new action potential (relative refractory period). The existence 
of a refractory period is vital for setting the frequency of ureteric peristalsis and it 
plays an important role in preventing hyperactivity in excitable tissues (Santicioli & 
Maggi, 1998). It has been suggested that the refractory period of the spontaneous 
action potential is due to the opening of three K+ channels- the Ca2+ activated K+ 
channel, the voltage dependent Ca2+ insensitive K+ channel and the K+ inward
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re c t if ie r  channel (E x in taris  e t a l., 1999).
Recently, the mechanism that underlies the refractory period in guinea pig ureteric 
smooth muscle has been clearly elucidated. This mechanism feeds back negatively to 
limit the excitability of the cells. The refractory period is mainly dependent on Ca2+ 
release from SR. In addition, inactivation of Ca2+ channels can regulate the myogenic 
component of the refractory period (Maggi et al., 1994; Burdyga & Wray, 2005).
After firing the action potential, the membrane depolarizes, Ca2+ flows into the cells 
and the SR is filled with Ca2+. As the SR Ca2+ content is increased, Ca2+ sparks are 
activated. This phase of excitability is followed by a subsequent phase of 
refractoriness. The increased Ca2+ sparks can activate plasmalemmal BKca channels 
and produce a transient after-hyperpolarization and cause the membrane inexcitability. 
This is the fundamental basis for the mechanism of refractoriness (Figure 1.5). At the 
end of the refractory period, the Ca2+ spark activity becomes the lowest (Burdyga & 
Wray, 2005). Therefore, BKca channel activity is decreased. After the refractory 
period is terminated, the stimulus can produce a new action potential (Wray et al., 
2005).
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Figure 1.5 Diagram illustrating molecular mechanism of refractory period in guinea
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pig ureter smooth muscle cells. Refractory period is mainly dependent on Ca release
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from SR. Ca entry into SR via Ca pump to generate Ca” sparks which activate
nearby BKca channels leading to membrane hyperpolarization.
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3 The mechanism of activation of smooth muscle contraction
Activation of smooth muscle contraction is triggered by a rise in intracellular Ca2+ 
either due to Ca2+ entry into the cell via L-type voltage-gated Ca2+ channels or Ca2+ 
release from intracellular SR store via IP3 receptors or ryanodine receptors. After the 
intracellular Ca2+ concentration has increased, there is more free Ca2+ in cytoplasm 
that can bind to calmodulin. Each calmodulin molecule can bind up four Ca2+ ions and 
cause a conformational change that results in exposure of the hydrophobic sites 
responsible for binding of myosin light chain kinase(MLCK) (Allen et al., 1994; 
Walsh, 1994). After this activation of calmodulin binding to the catalytic subunit of 
MLCK, it forms an active Ca2+/Calmodulin/MLCK complex that phosphorylâtes the 
Seri 9 of two myosin light chains and initiates the contraction.
3.1 Contractile proteins
Each smooth muscle cell contains thick filaments (mysosin) and thin filaments (actin). 
Smooth muscle contraction results from the formation of cycling cross-bridges 
between actin and myosin filaments. Skeletal muscle and smooth muscle share some 
muscle proteins including actin, myosin and tropomyosin. However, smooth muscle 
possesses specific isoforms of several proteins in contrast to skeletal muscle, 
including caldesmon, calponin and calmodulin. These proteins are abundant in 
smooth muscle and play an important role in its contraction (Rasmussen et al., 1987).
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3.1.1 Myosin
Myosin is a family of motor proteins that can move along actin. Myosin II has been 
found in smooth muscle and is responsible for smooth muscle contraction. Each 
myosin molecule is composed of two heavy chains (230kDa) and two pairs of light 
chains (20kDaand 17kDa each). Each myosin molecule contains two globular heads 
and a long, rod-like tail. The heads contain actin binding sites and ATP hydrolysis 
sites. Myosin light chain lies in the head part. The tail part contains two myosin heavy 
chains (Craig et al., 1983; Walsh, 1994). Myosin light chains have to be 
phosphorylated for binding actin (Kohama et al., 1996; Hatch et al., 2001). The 
movement of myosin along actin is ATP-dependent and is accompanied by ATP 
hydrolysis.
3.1.2 Actin
Thin-filament is chiefly composed of actin and a small amount of some other 
regulated proteins. Therefore, actin is often referred to as thin filament. Actin is a 
globular and about 42 kDa protein.
Thin filament may contribute to the regulation of “latch state” in smooth muscle. The 
thin filaments are capable of strong-binding or rigor-like cross bridge to “turn-on” the 
actin filament. The activated actin filament is also able to activate the 
unphosphorylated smooth muscle myosin in some types of smooth muscles and 
stimulate the formation of slowly cycling cross-bridges in the absence of calcium
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(Haeberle, 1999). Regulation of thin filament is essential for smooth muscle 
contraction. This can be achieved by modulation of its binding protein, such as 
calponin and caldesmon.
3.1.3 Calponin
Calponin is a homologous actin filament-associated protein of 292-330 amino acids 
expressed in both smooth muscle and non-muscle cells. Calponin binds to actin in a 
Ca2+-independent manner. The binding of calponin to actin inhibits the myosin 
MgATPase without affecting myosin phosphorylation. Calponin can be 
phosphorylated either by PKC or Calmodulin-dependent protein kinase II (CaM 
kinase II) and this leads to calponin-mediated inhibition of the myosin MgATPase 
(Winder et al, 1993).
3.1.4 Caldesmon
Same as calponin, caldesmon has been found in both smooth muscle and non-muscle 
cells. Caldesmon binds to actin to inhibit activation of myosin MgATPase activity. 
Therefore, caldesmon acts as an inhibitory mechanism to prevent smooth muscle 
uncontrolled contraction. The inhibitory effects of caldesmon can be reversed by 
binding of Ca2+/Calmodulin.
3.1.5 Calmodulin
Calmoduin is an important protein playing a key role in control of smooth muscle
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contraction. It is expressed in other types of muscle tissues, such as striated muscle, 
cardiac muscle which contraction is achieved mainly by the troponin/tropomyosin 
complex associated with the actin filaments (Weber & Murray, 1973). Smooth muscle 
does not possess troponin, but its contraction depends on calmodulin, which upon 
binding Ca2+ activates MLCK and phosphorylates myosin light chains to activate 
cross bridge cycling (Kohama et al., 1996).
Calmodulin is a Ca2+ binding protein. In addition to Ca2+, it can also bind various 
proteins including: caldesmon, calponin and CaM kinase II. These calmodulin binding 
proteins also contribute to the smooth muscle contraction. CaM kinase II contains 
three major domains: an N-terminal regulatory domain containing a Ser/Thr kinase 
site and Ca2+/Calmodulin binding site, a central-linker domain, and a C-terminal 
association domain. Activation of CaM kinase II results from Ca2+/Calmodulin 
binding to its regulatory domain and increases its affinity for Ca2+/Calmodulin 
(William et al., 2005). In turn, the activated CaM kinase II phosphorylates myosin 
light chain (Walsh et al., 1994).
Calmodulin has four Ca2+ binding sites, namely I, II, III and IV. Each binding site can 
bind one Ca2+ ion. After first two Ca2+ ions bind to calmodulin, a conformational 
change occurres. The hydrophobic sites of calmodulin are exposed which results in its 
binding to MLCK (Laporte et al., 1980). Occupation of at least three Ca2+ binding 
sites by Ca2+ is needed to activate the MLCK activity (Blumenthal et al., 1980).
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The relationship between myosin phosphorylation and force development is not linear 
(Rembold, 1992). The force can be maintained at a low phosphorylation level. It 
occurs with a decline in [Ca2+]i from its peak level but still higher than resting [Ca2+]i 
and a decreased activity of MLCK and low phosphorylation level of myosin light 
chain with a sustained force and reduced rates of cross-bridge cycling and ATP 
hydrolysis. This process is referred to as latch state which allows smooth muscle 
contraction with little energy expenditure (Dillon & Murphy, 1982; Harberle, 1999).
When the cytoplasmic Ca2+ concentration is restored to its resting levels, the 
relaxation of smooth muscle occurs. Calmodulin is dissociated from the Ca2+ and the 
Ca2+/Calmodulin/MLCK complex become inactive which results in a further decrease 
in MLCK activity. Myosin light chain phosphatase (MLCP) is Ca2+/Calmodulin 
independent, dephosphorylates myosin light chain which leads to relaxation (Haeberle 
et al., 1985; Himpens et al., 1988).
Phosphorylation of the 2 0 kDa myosin light chain (MLC20) facilitates actin myosin 
binding and initiates cross-bridge cycling. In general, MLC20 phosphorylation can be 
controlled by either Ca2+-dependent mechasnisms via activation of Ca2+/Calmodulin 
dependent MLCK or by Ca2+-independent mechanisms via regulation of MLCP 
activity by some kinases, including Rho-kinase and protein kinase C (PKC) (Kamm et
3.2 Mechanisms of regulation of Ca2+-sensitivity of contraction in smooth muscle
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al., 2001). MLCP can dephophorylate myosin light chain and lead to inactivation of 
actin-activated ATPase. Thus, phosphorylation of MLC20 can be modulated by both 
myosin light chain phosphatase and myosin light chain kinase.
3.2.1 MLCK
MLCK is an enzyme that catalyzes the phosphorylation of the myosin light chain 
(Herring et al., 2000). It contains a kinase catalytic subunit, a calmodulin binding site, 
an autoinhibitory site, and several structural motifs (Allen et al., 1994; He et al., 
2008). MLCK phosphorylates S19 of the MLC20 . At higher concentration, it also 
phosphorylates at T18 of myosin light chain (Ikebe et al., 1986). MLCK can bind to 
actin and myosin. MLCK activity is Ca2+/Calmodulin dependent.
At the resting state of smooth muscle, MLCK activity is inactive which is due to 
myosin-binding site being occupied by a pseudosubstrate domain (Walsh, 1994). 
Upon stimulation, the MLCK is activated by Ca2+/Calmodulin complex and the 
pseudosubstrate domain is removed therefore allowing myosin binding to MLCK.
3.2.2 MLCP
MLCP can dephosphorylate MLC2 0 . It contains 3 subunits: a large 110-130 kDa 
regulatory subunit which binds myosin (MYPT1), a 37-38 kDa catalytic subunit 
(PP1C) and a small 20kDa subunit whose function is unknown. Phosphorylation of 
the MYPT1 and the catalytic subunit reduces MLCP activity (Hartshome et al., 1998;
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Shimizu et a l, 1994).
Inhibition of MLCP occurs in response to various agonists (Deng et a l, 2002). Two 
ways has been identified in which the MLCP activity can be inhibited- one way is 
Rho kinase through receptor coupled to G proteins (Somlyo et a l, 2000); the other 
way is PKC action through receptor coupling with G q/n and PLC (Kitazawa et a l, 
2000).
3.2.3 Ca2+ sensitization
Ca2+ sensitization of smooth muscle reflects a ratio of activities of MLCK to MLCP. 
The level of phosphorylation of myosin light chain can be modulated by pushing the 
equilibrium between MLCP and MLCK.
Phosphorylation level of [MLC20] = function of (MLCK activity-MLCP activity)
Both increased MLCK activity or decreased MLCP activity produces an increase in 
MLC20 phosphorylation level which leads to activation of cross-bridge cycling and 
contraction of smooth muscle at a constant level of cytoplasmic free Ca2+ 
concentration. Conversely, decreased MLCK activity or increased MLCP activity 
leads to decreased MLC20 phosphorylation and inactivation of actin-activated myosin 
ATPase. When Ca2+ desensitization occurs there is a decline of force and MLC20 
phosphorylation at the constant level of the intracellular [Ca2+]i (Himpens et a l, 
1989).
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The Ca sensitization mechanism in smooth muscle involves inhibition of MLCP by 
agonist binding ligand receptors, G proteins, and guanine nucleotide-binding factors 
(Somlyo et al., 2003). This can be regulated by either Rho A/Rho Kinase mechanism 
or CPI-17/PKC action which is discussed in detail below.
3.2.4 Agonist-induced contraction
In smooth muscle, binding of an agonist to its receptor on the cell membrane induces 
a series of signal transduction steps which eventually initiate smooth muscle 
contraction. In addition, the sensitivity of the contractile apparatus to Ca2+ can be 
regulated by agonists. In smooth muscle, two mechanisms have been found so far 
which is involved in regulation of agonist induced Ca2+ sensitization:
(1) Agonists (such as cabachol, oxytocin) can bind to G-Proteins of the Gqm family on 
plasmalemma membrane which in turn activates phospholipase C (PLC). PLC can 
mediate hydrolysis of PIP2 into inositol 1.4.5-trisphosphate (IP3) and 
1,2-diacylglyceral (DAG) respectively. IP3 binds to its receptor on the SR surface and 
causes Ca2+ release from SR. DAG activates PKC (Walsh, 2007). PKC in turn 
phophorylates CPI-17 at Thr38 and enhances its inhibitory potency of MLCP. The 
myosin light chain kinase/myosin light chain phosphatase ratio is moving towards 
MLCK, resulting in an increase in myosin light chain phosphorylation (Figure 1.6 ).
(2) Agonists can also bind to G„q / G012,13 coupled receptors to activate RhoA and its 
downstream effectors. In the resting state, the inactivated form of RhoA is bound to 
RhoGDI (guanine nucleotide dissociation inhibitor). The RhoA/RhoGDI complex can
2+
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be activated by Rho-GEFs (guanine nucleotide exchange factors) to exchange GDP 
for GTP on RhoA and the activated RhoA is dissociated from the complex and 
translocates to the plasma membrane and in turn activates the Rho-kinase. The 
activated Rho-kinase phophorylates the regulatory subunit of MLCP and therefore 
inhibits MLCP activity (Cherfils & Chardin, 1999; Somlyo et al., 2000).
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Figure 1.6 Diagram showing possible mechanism of agonist-induced smooth muscle 
contraction. Agonist (A) binds to its receptor (R), activates plasma membrane PLC,
I
and increases production o f IP3 and DAG. IP3 stimulates Ca release from the SR. 
DAG activates PKC. PKC phosphorylâtes CPI-17, which in turn inhibits MLC 
phosphatase and thereby increasing the myosin light chain phosphorylation level and 
force in Ca2+-independent way. (Figure modified from Salamanca, D. A. and Khalil, R
A. 1995).
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3.2.5 RhoA/ROCK pathway
RhoA is a small about 20 kDa monomeric GTPase protein. RhoA can be activated 
when it is bound to GTP (referred to Rho GTP) and is inactivated when it is bound to 
GDP. The activated RhoGTP in turn stimulates Rho-kinase, which is serine/threonine 
kinase and it plays an important role in various cellular functions. Rho-kinase contains 
a Rho-binding domain and can be activated by RhoGTP (Leung et al. 1995; Matsui et 
al. 1996). The process of activation of Rho-kinase requires RhoA GTP translocation 
to the plasma membrane (Gong et al. 1997; Taggart et al. 1999). In addition, 
Rho-kinase can be activated by arachidonic acid and contributes to Rho-kinase 
mediated Ca2+ sensitization (Fu et al., 1998; Feng et al., 1999). Rho-kinase 
phosphorylates MLCP 130kDa myosin binding sites and therefore inhibits MLCP 
activity (Kimura et al., 1996) resulting in enhancement of MLC20 phosphorylation and 
smooth muscle contraction at a constant level of [Ca2+]i.
Rho-kinase has been shown to play an important physiological role in modulation of 
smooth muscle contraction in a variety of smooth muscles. In tonic smooth muscle, 
Y-27632 (Rho-kinase inhibitor) can reduce blood pressure without affecting normal 
blood pressure (Uehata et al., 1997). In ureter smooth msucle, Rho-kinase has been 
shown to be involved in the excitation-contraction coupling in two ways-Ca2+ 
dependant and Ca2+ independent mechanism (Shabir et al., 2004). The inhibition of 
Rho-kinase affects the duration of action potential, Ca2+ transient and force by 
targeting the L-type voltage-gated Ca2+ channels (Ca2+-dependant pathway) (Shabir et
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al., 2004). In addition, Rho-kinase was also found to modulate the ureter smooth 
muscle contraction in a Ca2+-independent way by modulating MLCP activity. The 
effect of Rho-kinase on ureter smooth muscle is species dependent which is only 
shown in rat but absent in guinea pig ureter smooth muscle (Shabir et al., 2004).
3.2.6 CPI-17 and PKC
CPI-17 is 17 kDa peptide. It can inhibit type 1 serine/threonine phosphatase, such as 
MLCP. Phosphorylation of CPI-17 at Thr38 by PKC increases its inhibitory potency 
about 1000 fold. In addition to PKC, some other kinases can also phosphrylate the 
Thr38 site of CPI-17, such as ROCK, PKN and PKA (Koyama et a l, 2000; 
Hamaguchi et al., 2000; Takizawa et al., 2002). CPI-17 inhibits the catalytic subunit 
of MLCP, which provides an independent pathway for MLCP inhibition without 
affecting its myosin binding subunit (Li et al., 1998; Kitazawa et al., 2000).
Inhibition of Rho-kinase with Y-27632 and PKC with GF109203X reduced CPI-17 
phosphorylation and decreased contraction suggest that Rho-kinases and PKC are 
downstream of CPI-17 (Kitazawa et al., 2000, 2003).
Some studies show that activation of conventional or novel PKC by phorbol esters 
and diacylglycerol (DAG) can inhibit the activity of MLCP (Ioh et al., 1993; Masuo et 
al., 1994). The PKC activator induced Ca2+ sensitization independently of changes of 
[Ca2+]i and can not be inhibited by Y-27632 (Fu et al., 1998). It suggests that PKC
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activation induces Ca2+ sensitization by inhibiting MLCP activity but it is not through 
the RhoA/ROCK pathway. PKC physiologically modulate Ca2+ sensitization by 
phosphorylation of CPI-17.
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4 Ca2+ signaling in ureter smooth muscle
4.1 Role of extracellular calcium
At rest, [Ca2+]i in majority of smooth muscle cells is 0.1-0.2 pM. Upon stimulation, 
[Ca2+]j can rise up to 0.5-0.7 pM either due to Ca2+ entry via voltage-gated or 
receptor-operated Ca2+ channels or Ca2+ release from sarcoplasmic reticulum (SR) 
(William & Fay, 1986; Allen & Walsh, 1994). So far, it is known that Ca2+ entry into 
the cell provides a major triggering source to initiate smooth muscle contraction. In 
ureter smooth muscle, Ca2+ entry via L-type Ca2+ channels plays a key role in control 
of phasic contraction (Carlo et al., 1995). [Ca2+]j is maintained by a number of 
mechanisms which include Ca2+ extrusion from cell by a Ca2+ pump in the plasma 
membrane and the Na+-Ca2+ exchanger. Ca2+ can also be sequestered into intracellular 
store by SERCA pump on SR membrane.
4.2 Role of the SR
In addition to Ca2+ entry from the extracellular fluid, Ca2+ release from the 
intercellular store can also play an important role in control of the Ca2+ signaling in 
ureter smooth muscle.
The SR functions as an internal Ca2+ store uptaking and releasing Ca2+ from the store. 
Ca2+ can be taken into the SR by SERCA pump from the cytoplasm by expense of 
ATR Generally, in smooth muscle, two types of intracellular Ca2+ release channels 
have been characterized: Ryanodine receptor (RyR) and Inositol 1,4,5-trisphosphate
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(IP3) receptors. They are responsible for removing the Ca2+ from the internal store.
Role of the SR function in smooth muscles is still poorly understood. In tonic smooth 
muscle, Ca2+ release during agonist stimulation can contribute to generation of 
vascular tone via generation of Ca2+ oscillations which appear in the form of 
propagating Ca2+ waves (Wray et al., 2005). Both IP3R and RyR channels have been 
reported to be involved in generation of Ca2+ oscillations. In phasic smooth muscle, 
such as bladder, activation of RyR channels can be triggered by Ca2+ entering the cell 
via L-type Ca2+ channels so called Ca2+-induced Ca2+ release (CICR) and thus acts as 
an amplifying mechanism. In ureter smooth muscle, CICR is confined to 
microdomain and appear as localized Ca2+ sparks which act as a negative feedback 
mechanism to control ureteric excitability (Burdyga & Wray, 2005).
4.3 Ca2+ sparks
Ca2+ spark is a small local Ca2+ release event from clusters of RyR on the SR. The 
area where the Ca2+ is discharged is called frequent discharge site. In guinea pig ureter, 
this site is present and enriched with RyRs (Wray et al., 2005). Smooth muscle cells 
have different isoforms of RyR subtypes RyRl, RyR2, and RyR3, but it is unclear that 
which isoform is necessary for Ca2+ sparks activity in ureter smooth muscle.
Ca2+ release via RyR channels can be activated by Ca2+ entering the cell through the 
voltage-dependent Ca2+ channels by activation of CICR mechanism. Caffeine can
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facilitate CICR by sensitizing RyR to Ca2+. In guinea pig ureter smooth muscle, 
caffeine can activate Ca2+ release from the SR producing an inhibition of action 
potential, phasic contraction and Ca2+ transient (Borisova et al., 2007). However, it is 
not observed in rat ureter smooth muscle. Furthermore, Ca2+ sparks can be detected in 
guinea pig ureter but not in rat (Burdyga, et al., 1998). These differences can be 
explained by the different IP3 and RyR expression in the two species. Rat ureter was 
reported to express mainly IP3R (Boiffin et al., 2000; Burdyga et al., 1995, 1998).
4.4  Ca sparks/STOCs coupling mechanism in ureter smooth muscle
Ca2+ sparks can activate BKCa channel on the membrane to generate STOCs which is 
found in both guinea pig and rat ureter smooth muscle and is dominant in guinea pig. 
This Ca2+ sparks/STOCs coupling mechanism plays an important role in control of 
excitability in ureter smooth muscle.
Loading the SR store with Ca2+ facilities generation of Ca2+ sparks. Ca2+ sparks 
activate BKca channels to produce STOCs and lead to membrane hyperpolarization 
and decrease the tissue excitability. Ca2+ sparks/STOCs coupling mechanism acts as a 
negative feedback mechanism to limit the cell membrane excitability (Figure 1.7).
Regulation of Ca2+ sparks/ STOCs coupling mechanism can affect not only the 
membrane excitability but also the duration of plateau component of the action 
potential, Ca2+ transient and phasic contraction in guinea pig ureter smooth muscle.
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Activation of Ca2+ sparks by low concentration of caffeine increases the amplitude, 
frequency and kinetics of Ca2+ sparks and STOCs leading to hyperpolarization of the 
guinea pig ureter smooth muscle cells which results in an inhibition of the contractile 
activity. This effect of caffeine can be reversed by ryanodine or CPA or BKca channel 
blocker TEA (Borisova et al., 2007).
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2_j_
Figure 1.7 Ca sparks /STOCs coupling mechanism in the guinea pig ureter smooth
2+
muscle. Depolarization o f membrane opens the L-type Ca channel results in an
2+ 2+
increase in intracellular Ca leading to Ca loading into SR. Increase in luminal
2_j_
[Ca2+]i activates spontaneous Ca sparks which could hyperpolarize the membrane by 
activating STOCs via Ca2+ sparks/STOCs coupling mechanism acting as a negative 
feedback mechanism to decrease cell excitability and duration o f the plateau 
component o f action potential.
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4.5 Ca2+ puffs
There are three isoforms of IP3 receptors, referred to IP3RI, IP3R.2  and IP3R.3 . The
2+
opening of clusters of IP3 receptors can induce the spontaneous transient local Ca 
release events, named Ca2+ puffs. The mechanism of Ca2+ release from IP3 receptors is 
referred as nVinduced Ca2+ release (IICR). Agonist induced Ca2+ release from the SR 
can be activated in rat ureter smooth muscle. In rat ureter, IICR targets Clca channels 
and depolarizes the cell membrane and increases the Ca2+ entry into the cell via 
L-type Ca2+ channel (Burdyga et al., 2002). Carbachol can evoke a contraction which 
is insensitive to ryanodine but can be blocked by heparin and cyclopiazonic acid in rat 
ureter, therefore, it is suggested that IP3 expresses exclusively in rat ureter. (Burdyga 
et al., 1998).
In some types of smooth muscles, both IP3 receptor and ryonadine receptor 
simultaneously localized at the surface of SR store and interact with each other. 
Inhibition of IP3 decreased frequency of Ca2+ sparks in rabbit portal vein myocites. In 
contrast, inhibition of IP3 increased the frequency of Ca2+ sparks in guinea pig vas 
deferens smooth muscle cells (White et al., 2003).
4.6 Ca2+ waves
The small localized Ca2+ release, Ca2+ sparks and Ca2+ puffs, can develop into Ca2+ 
waves (Wray et al., 2005). The Ca2+ transient observed in intact smooth muscle 
preparation, propagating within individual muscle cells is also referred to as a Ca2+
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wave. Ca2+ release from SR provides an elementary events leading to Ca2+ waves 
which is caused either due to the intracellular Ca2+ release via IP3 receptor or via RyR. 
In addition, agonists can induce smooth muscle contraction by initiating or amplifying 
Ca2+ wave activity by activation of PLC (McCarron et al., 2002).
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5 Smooth muscle and PKC
5.1 Smooth muscle
Generally, there are three types of muscles: smooth muscle, skeletal muscle and 
cardiac muscle. Smooth muscle is so called because of its distinguished characteristic 
lack of visible cross striations. Smooth muscle is responsible for the contractility of 
hollow organs, such as ureter, blood vessels, uterus and the airway. It maintains 
homeostasis and adaptive responses to stresses (He et al., 2008). The impaired 
contraction of smooth muscle underlies several diseases including hypertension and 
bronchial asthma (Ihara et al., 2007).
There are two types of smooth muscle in the body: multi-unit and visceral smooth 
muscle. Most of the internal hollow organs are visceral muscle which can be divided 
into phasic smooth muscle (ureter and uterus) and tonic smooth muscle (stomach 
fundus) based on the characteristics of contractile patterns and whether the 
spontaneous activity is present. The phasic smooth muscle like ureter and uterus 
contract and relax rapidly. The tonic smooth muscle contract slowly and may maintain 
the contraction for a prolonged periods.
5.2 PKC isoform and structure
Protein kinase C (PKC) is a family of serine threonine kinases. PKC family is divided 
into 3 groups: conventional, novel and atypical. Conventional PKC (cPKC) includes a, 
P and y isoform. It requires Ca2+, DAG, a phospholipid such as phosphatidylcholine
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for activation. Novel PKC (nPKC) includes 8 , s and 0 isoform. It requires DAG, but 
do not require Ca2+ for activation. Thus, conventional and novel protein kinases C are 
activated through the same signal transduction pathway as phospholipase C. Atypical 
protein kinases C (aPKC) include £ and XA isoform. Their activation are not 
dependent on Ca2+ or DAG.
Generally, PKC family consists of a catalytic domain and a regulatory domain. The 
regulatory domain is the site binding to phorbol/DAG (Cl) or Ca2+ (C2). While the 
catalytic domain contain ATP (C3) and a substrate binding site(C4). The conventianal 
PKC has C1-C4 domain; the novel PKC isoform do not have the C2 region therefore 
do not require Ca2+ for activation.; the atypical PKC has only part of the Cl region 
and lack of C2 region therefore it is not affected by phorbol esters, DAG and 
Ca2+(Salamanca et al., 2005) (Figure 1.8).
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Figure 1.8 Structure of PKC isoforms. PKC consists o f regulatory domain (C l and C2) 
and catalytic domain (C3 and C4). (Figure modified from Salamanca, D. A. and 
Khalil, R A. 1995).
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Stimulation of smooth muscles by GPCR by agonists leads to hydrolysis of PIP2 and 
subsequent production of second messengers IP3 and DAG.. DAG activates PKC and 
results in its translocation from the cytosol to the plasma membrane. Activation of 
PKC in turn induces a series of signal transduction in smooth muscle contraction 
including modulation of MLCP via CPI-17 and thereby affecting MLC20 
phosphorylation.
PKC can be activated by the fatty acid derivative DAQ with Ca2+ acting as a cofactor 
for some isoforms. PKC can bind to Ca2i in a phospholipid-dependent mechanism in 
addition to DAG. Calcium exerts its effect as a bridge between PKC and 
phospholipids (Bazzi et al., 1990). PKC activator includes Phorbol esters, such as 
TPA, PMA and PDBu, which are the substrates for DAG in PKC activation. PKC 
inhibitors acting on the catalytic domain such as H-7 and Staurosporine are not 
specific. However, PKC inhibitors acting on the regulatory domain and competing at 
the DAG/ phorbol ester or the phosphatidylserine-binding site are more specific. This 
kind of inhibitors includes Calphostin C and Sphingosine (Salamanca et al., 2005). 
However, the molecular effect of PKC specific inhibitor GF109203X and Ro320432 
on PKC region is not clear. Ro320432 has been shown to inhibit specifically PKC 
isoforms a, pi, pil, y and e. GF109203X has specific inhibitory effect on isoforms a, 
pi, 8 , s, and C,. Rottlerin has been shown to be a specific PKC8  inhibitor.
5.3 Signal pathways involving PKC in smooth muscle
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5.4 Function of PKC in smooth muscle
5.4.1 Ca2+ sensitization
PKC has been demonstrated to play a crucial role in regulation of several types of 
smooth muscle contraction, i.e. vascular, gut and airway smooth muscle (Murthy, 
2005). In tonic smooth muscle such as arterial smooth muscle, activation of PKC 
enhances the force without or little change of intracellular free Ca2+ concentration by 
raising the sensitivity of the myofilaments to intracellular free Ca2+ (Rasmussen et al., 
1984, Chatterjee & Tejeda, 1986; Ruegg, 1999). This mechanism has been 
demonstrated recently to be achieved by inhibition of MLCP through mediation of a 
novel RACK- CPI-17 (Kitazawa et al., 1999).
Agonists such as histamine or KC1 can enhance the force which is associated with 
increased PKC activity (Singer et al., 1992). In bovine and human airway smooth 
muscle, PKC is involved in the histamine induced contraction (Yang & Black, 1995; 
Boterman et al., 2005). It suggests that agonists such as histamine activate PLC, 
producing an increase of IP3 and DAG production and therefore activation of PKC 
(Boterman et al., 2005).
5.4.2 PKC and ion channels
PKC has effect on plasma membrane channels and therefore membrane excitability. 
Activation of PKC is shown to inhibit BKca channel activity in pulmonary vascular 
smooth muscle (Bamab et al., 2004; Crozatier et al., 2006; Ledoux et al., 2006). The
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agonists endothelin-1 and angiotensin II inhibit K;r channel activity by activating PKC 
(Park et al., 2008). PKC can also exert its effect on Ca2+ release from SR therefore 
affecting the activity of target channels and smooth muscle contraction. In vascular 
smooth muscle, activation of PKC decreases Ca2+ spark activity and therefore 
decreases STOCs frequency and hence modulation of membrane potential (Bonev et 
al., 1997). In mouse airway smooth muscle cells, PKC activator inhibits Ca~+ sparks 
activity. Inhibition of PKC activates Ca2+ sparks frequency, which is due to the 
modulation through PLC and DAG (Liu et al., 2007). Furthermore, in rabbit portal 
vein smooth muscle cells, the enhanced L-type Ca2+ channel activity is associated 
with activation of PKC (Ding et al., 2004).
To our knowledge, nothing is known whether PKC is expressed and functionally 
important in phasic ureter smooth muscle. Therefore, in this study we have 
investigated possible role of PKC in control of ureteric contractility.
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Hypothesis and Aims:
Hypothesis:
In many types of smooth muscle, e.g., vascular and bladder, PKC is involved in 
control of smooth muscle contraction. Therefore, we hypothesized that PKC is 
important in the regulation of excitation-contraction coupling mechanism in guinea 
pig and rat ureter smooth muscle.
Aims:
I. Using western blotting and immunohistochemistry to investigate the expression and 
distribution of different PKC isoforms in the guinea pig and rat ureter.
II. To study the effects of direct PKC activation and inhibition on the 
excitation-contraction coupling in the guinea pig and rat ureter smooth muscle by 
using different experimental models and protocols which include:
1. Investigation of the effects of PKC activator PDBU and PKC inhibitor Ro320432 
on the temporal relationship between Ca2+ transients and force for phasic contraction 
evoked by electrical field stimulation in both guinea pig and rat ureter smooth muscle;
2. Elucidation of role of Ca2+ sparks/STOCs coupling mechanism and Na+-Ca2+ 
exchanger in the effects of PKC activation on force-Ca2+ relationship in the ureter 
smooth muscle;
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3. Investigation of functional role of Ca2+ sensitization in modulation of contractile 
activity by PKC activation in ureteric smooth muscle by using different experimental 
models and protocols;
III. To investigate possible role of PKC in the stimulant effects of agonists in the 
ureteric smooth muscle.
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Chapter 2
Materials and Methods
Chapter 2 Materials and Methods
2.1 Animals
The ureters were obtained from male guinea pigs (300-400g) and male or female 
Wistar rats (250g). Animals were humanely killed by exposure to CO2 in 
accordance with Animals (scientific procedures) Act of 1986. This was followed 
by cervical dislocation. The ureters were dissected and cleared of any connective 
tissues and fat and cut into small strips around 3-4mm in length under a dissection 
microscope. All ureters were immersed in buffered physiological Krebs solution 
(see 2 .2 ) after isolation from the animal.
2.2 Solutions and chemicals
All chemicals and solutions were obtained from Sigma (Dorset, UK) unless 
otherwise stated.
In the experiments measuring force and calcium, the ureteric strips were 
continuously immersed in physiological Krebs solution buffered containing (mM): 
124 NaCl; 5.4 KC1; 1.2 MgS04; 11 HEPES; 11.7 Glucose and 2 CaCl2. The pH of 
the solution was adjusted by using sodium hydroxide (NaOH) to 7.40. The high 
potassium solution (120mM) was prepared by isosmotic replacement of 120mM 
NaCl with KC1. Zero sodium solution (Tris substitution) containing 110 Tris base;
5.6 KC1; 1 MgS04; 10 HEPES; 10 Glucose and 2 CaCl2. The pH of the solution 
was adjusted using HC1 (10M) to 7.4. Zero calcium Krebs solution was prepared 
by omitting CaCl2 and contained 2mM EGTA. Hank’s solution (GibcoBRL; pH 
7.4) containing 136 NaCl; 5.4 KC1; 4.17 NaHC03; 6.7 Na2HP04; 0.44 KH2P 04;
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5.5 glucose and 0.04 CaC^ then was bubbled with O2 . KB medium solution used 
during cell isolation containing 40 KCL, 10 K2HPO4, 10 taurine, 10 TES, 11 
glucose, 5 pyruvate, 5 creatine, 0.04 EGTA, 100 K-glutamate, The pH of the 
solution was adjusted by using potassium hydroxide (KOH) to 7.40. Details on 
other stock solutions are given in the individual chapters.
2.3 Simultaneous measurements of force and intracellular calcium
2.3.1 The fluorescent indicator of free cytosolic calcium - Indo-1
Indo- 1  is a ratiometric dye that can be used to indicate the change s in intracellular 
calcium concentration. The indicator is excited by UV light at a wavelength of 
3 5 5 nm and emits light at a specific wavelength, which depends upon whether or 
not it is bound to calcium. In the absence of calcium, Indo-1 emits more 500nm 
wavelength light, and when calcium is bound to the molecule, Indo-1 emits more 
400nm wavelength light. The ratio of these two wavelengths gives an indication 
of the change in intracellular calcium in the cells. However, it is not an indicator 
for absolute cytosolic calcium concentration. Since a ratio of the two wavelengths 
is used, any additional effects of the concentration of the indicator, the 
illumination intensity and any movement artifacts can be ignored (Cobbold & 
Rink, 1987). In this study, Calcium sensitive dye Indo-1 acetoxymethyl ester 
(Indo-1 AM, Molecular Probes, Oregon, USA) was used to measure the 
intracellular free cytosolic calcium. Indo-1 AM is a cell membrane permeable 
form of indo- 1  so that it can help indo- 1  indicator diffuse passively across cell 
membranes. After it enters into the cells, the AM esters can be cleaved from 
indo-1 AM by cytosolic esterases.
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2.3.2 Tissue loading with Indo-1 AM
Indo-1 AM was supplied in the anhydrous form (50pg vials) and made into a 
ImM stock solution dissolved in 50pl of dimethyl sulphoxide (DMSO) containing 
20% (w/v) of non-ionic detergent pluronic acid (F-127 Molecular Probes, Oregon, 
USA) to mix the indo-1 AM in aqueous solutions. A 20pM indo-1 AM solution 
was used to load the ureter by adding 40pL of the indo-1 AM stock solution 
containing the pluronic acid to 2ml of Krebs solution. The dissected ureter strips 
were then loaded on a rotator for 3 hours at room temperature. After loading, the 
ureters were washed with Krebs solution to remove any excess Indo-1 AM prior 
to experiments. Then the ureteric strip was cut into 3-4 mm strips and clipped with 
aluminum foil shaped clips.
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EveDiece
Figure 2.1 Schematic diagram of apparatus designed for simultaneous measurement of force 
and calcium. Ultraviolet illumination is provided by xenon lamp while the heat filter (1) and 
neutral density filter (2) block excess heat and reduce the light intensity, respectively. The 
appropriate wavelength of light at 355nm was selected by the interference filter (3) the 
mechanical shutter (4 ) is used to ensure the tissue is only illuminated for the minimum 
amount of time required. The light is reflected upwards towards the tissue by a dichroic 
m irror (DM1) and focussed onto the preparation by a lens. The emitted light then passes back 
through the lens and dichroic mirror and is reflected through a sliding mirror through a 
diaphragm (5) onto another dichroic mirror (DM2). Light with a wavelength longer than 610 
nm is directed to a video camera that can be used to produce an image of the tissue on monitor, 
light with a wavelength less than 610 nm is directed to a third dichroic mirror (DM3). The 
light is spilt by a DM3, passing to either the 400 nm or 500nm photomultiplier tubes (PMT). 
In front of each PMT there is an emission filter at the appropriate wavelength (6 ). Figure 
designed by Dr S. Shabir.
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2.3.3 Simultaneous measurement of force and calcium
The experiment was performed in a Faraday cage in a dark room to reduce the 
electrical interference and to avoid background illumination. The ureter strips 
loaded with Indo-1 were placed in the apparatus shown in Figure 2.1 in order to 
perform the experiment to simultaneously measure the force and intracellular 
calcium. One end of the ureteric strip with clips was attached to a fixed hook and 
the other end was placed over a force transducer (Grass FT03, Massachusetts, 
USA) in a constant perfusion organ bath. The ureteric strip loaded with Indo-1 can 
be excited at 340 nm and emitted light at wavelength of 400nm and 500nm was 
collected. The ratio of these emissions was used to estimate changes in 
intracellular calcium.
The ureteric strips loaded with indo-1 were mounted in a small chamber over the 
stage of an inverted microscope (Nikon Diaphot, USA) equipped with a 20 x 
Fluor objective. Experiment on the guinea pig ureteric smooth muscles was 
routinely performed at 33°C; all the experiment on rat ureter was performed at 
room temperature. The bottom of the chamber was sealed with a glass coverslip 
using high vacuum grease (Dow Coming). The tissue was continuously perfused 
with buffered Krebs solution (pH 7.4) at a flow rate of 4ml.min'1. When 
performing an experiment in which a solution with a high potassium 
concentraction was used to stimulate the muscle, a flow rate of 9 ml.min' 1 was 
used to ensure that the flow of solution in the organ bath occurred as quickly as 
possible. Phasic contractions were induced by electrical field stimulation (EFS) 
using Ag/AgCl electrodes with rectangular pulses of amplitude 5-7V and 100msec
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duration at around 40 seconds intervals. The optimal length (Lo) of the muscle 
strip was determined by stretching the muscle to a passive force which was 
20-30% of the force generated during high K+ response. Normally at this length, 
the preparations showed maximum force responses.
UV light emitted by a xenon lamp, filtered at wavelength of 355nm, was used to 
excite the Indo-1 Ca2+ sensitive indicator in the tissue. The light emitted by the 
Indo-1 loaded tissue was obtained at wavelengths 400nm and 500nm and 
monitored via photomultiplier tubes and changed into ratio by using a Digidata 
1200 board and Axoscope 8  software (Axon instruments) on the computer. The 
increase in intracellular calcium concentration shift the indo- 1  fluorescence 
spectrum to UV direction and produce an increase in fluorescence at the 
wavelength of 400 nm and a decrease at the wavelength of 500 nm. Only when 
the two wavelength move in the opposite direction the signal was used. The force 
and calcium signal were recorded at a sampling rate of 100Hz. This was to ensure 
that rapid changes in intracellular calcium and force could be recorded correctly. 
Figure 2.2 shows a typical trace of the record to simultaneously measure force and 
intracellular calcium. The ratio of the emitted light at 400nm and 500nm 
wavelength (F400/F500) is shown, which indicates the change in intracellular 
calcium.
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Figure 2.2 Simultaneous measurement of force and intracellular calcium. Force 
(black) and fluorescence emissions of ureter tissue loaded with Indo-1 
wavelengths of collected light at 400nM (green) and 500nM (blue) were recorded. 
Change in intracellular calcium (red) obtained as the ratio of 400/500 emissions.
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2.3.4 Calibrating the force
Force obtained from the experiment was measured in Newton (N). The force 
transducer converted the force of contraction of the smooth muscle into an 
electrical signal that was recorded on a computer using Axoscope software. The 
force was calibrated by comparing the signal obtained from the transducer to force 
produced by a known weight. The signal obtained converted to force was done by 
using the equation N=kg.m.s ' 2 where 1kg is 9.8N.
2.4 Identification and distribution of PKC isoform 
2.4.1 Protein extraction and quantification
Rat and guinea pig ureters and samples from skeletal muscle, airway smooth 
muscle and brain tissue were dissected and rinsed and homogenized in protease 
inhibitor solution containing RIPA buffer (1 X PBS, 0.5% sodium deoxycholate,
0.1% SDS) at a volume o f 3ml/g tissue, O.lmg/ml PMSF, lpM  sodium 
orthovanadate and 30pl Aprotinin under ice. The samples were centrifuged at 
10,000g for 10 minutes at 4°C then the supernatant was removed and 
recentrifuged at 10,000g for 10 minutes at 4°C and the supernatant was removed. 
The protein quantification was carried out using the BioRad protein Assay. The 
tissues were diluted on a range from 1:10 to 1:100 in RIPA buffer. The samples 
and standards (BSA+dH2 0 ) were mixed with the BioRad Dc working reagent 
with 20 pi reagent S per 1ml reagent A. Then the reagent B was added to the 
samples and standards and incubated at room temperature for 10 minutes. The 
protein concentration was calculated by comparing the 750nm light absorption 
through the unknown sample with the equivalent value on the graph of 750nm
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absorption/BSA concentration using Microsoft Excel software.
2.4.2 SDS-PAGE
Protein extracts were mixed with RIPA buffer and solubilized in equal volumes of 
reducing sample buffer containing 0.5M Tris-HCl pH 6 . 8  (Sigma), 4% SDS, 20% 
glycerol, 10% 2 -mercaptoethanol, 0.004% bromophenol blue, and heated at 95°C 
for 3 minutes. SeeBluePlus2 (Invitrogen) was used as molecular marker.
2 0 pl of sample containing 50 pg protein was loaded per lane and was resolved 
using a 4% polyacrylamide stacking gel. The proteins were then separated on a 
12% polyacrylamide gel. The gel was electrophoresed on a Bio-Rad Protean II 
system for 30 minutes first at a 80V until the sample ran through the stacking gel 
and then ran at 120V for about 1 hour until the blue dye reach the bottom of the 
gel. The running buffer containing 5mM Tris-Base(Sigma), 36.4mM 
Glycine(Sigma), 0.02%SDS(Sigma) and pH8.3 in a solution of 600ml. The PVDF 
membrane was pretreated in methanol for 1 0  seconds, washed in dHiO and then 
left to equilibrate in transfer buffer for 10 minutes containing 250mM Tris-Base, 
192mM glycine, 20% methanol. The protein was then transferred to PVDF at 55V 
for 1 hour. Then the PVDF was incubated in block solution containing 5% non-fat 
milk power, 0.1%TWEEN 20 in TBS overnight at 4°C.
The next day the PVDF was washed three times for 5 minutes in TBS with 0.1% 
Tween 20. The membrane was incubated with primary antibody PKC isoform a, P, 
8  and e (BD Biosciences) diluted in blocking solution each being adjusted at the
65
optimized concentration for PKCa, (3, 8  and e for 1 hour at room temperature. 
After washing 5 times for 5 minutes with PBS-0.1%Tween, the membrane was 
incubated with secondary antibody (rabbit anti-rat 1:5000) in blocking solution for 
1 hour at room temperature. The membrane was then washed three times for 5 
minutes in TBS Tween 20 and once in TBS for 5 minutes. The membrane was 
incubated in Supersignal West Pico Chemiluminescent Substrate and exposed to 
Hyperfilm ECL film (Amersham Biosciences) for 10 sec to 5 minutes and 
developed using a Kodak auto-developer (Kodak, Hemel Hempstead, UK). 
Positive controls airway smooth muscle and brain tissue and negative controls 
were also used.
2.4.3 Immunohistochemistry
Tissue was placed in neutral buffered formalin for 24 hours. Then the ureter was 
placed in PBS to prevent over-fixation of formalin. Ureter was then placed in 
processor, passed through different levels of formalin and alcohol and then was 
embedded in was. Thin sections were obtained by using microtone.
The slides were incubated in xylene for 30 minutes at room temperature to 
remove the paraffin wax from the tissue, followed by rehydration in a series of 
freshly made alcohol baths at 100%, 95%, 85%, 70% and 50% and washed in 
distilled water for at least 5 minutes. Antigen retrival was performed by placing 
slides into the heated 0.01M citrate buffer at pH 6  and boiling for 12 minutes. The 
slides were then transferred to distilled water for 5minutes and incubated with the 
dual endogenous enzyme block from the DAKO envision kit (DAKO Cytomation)
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for 20 minutes. After this, slides were rinsed in distilled water and washed for 15 
minutes in wash solution bath (TBS with 0.05% Tween 20). The slides were 
incubated with wash solution containing BSA albumin for 30 minutes. Then the 
primary antibody PKC a, p, 8 , e (1:100 dilution each) (BD Biosciences) was 
diluted in TBS-Tween with 1% bovine serum albumin solution, added onto the 
slides and incubated overnight at 4°C. The next day, the slides were rinsed 
TBS-Tween solution three times for 5 minutes with gentle agitation, and then 
incubate with DAKO Envision polymer (DAKO Cytomation) and then exposed to 
DAB substrate (DAKO Cytomation) for 10 minutes. The image was captured 
using Nikon MicrophotFX microscope fitted with a Nikon DXM1200 digital 
camera.
2.5 Confocal imaging of isolated ureteric myocytes
2.5.1 Cell isolation
After cleaning the ureters were cut into small pieces and placed into Ca2+ free 
Hanks solution and used for cell isolation. The pieces of ureter for cell isolation 
were washed with Hanks solution at 35°C twice for 15 minutes. After washing, 
the ureteric strips were transferred into solution containing collagenase Type I 
(0.3 mg/ml), protease (0.15 mg/ml), trypsin inhibitor (0.2 mg/ml) and BSA (1 
mg/ml), for 40 minutes at 35°C. The tissue was then placed in KB media and after 
15 minutes was triturated by a fire-polished Pasteur pipette. Dispersed cells were 
filtered, centrifuged at 2000 rpm for 2 min and then placed into fresh KB media 
containing 5pM Fluo-4 AM and Pluronic F-127 for loading for 30 minutes at 
room temperature. After loading cells were centrifuged and placed into dye -  free
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KB media and kept for 30 minutes at room temperature and then refrigerated until 
use. Cells were excited at 488 nm using Argon -Krypton gas laser and Fluo-4 
fluorescence was measured at 5 lOnm and used as a measure of [Ca2+]i, Changes in 
fluorescence were expressed as a pseudo-ratio of F/Fo where Fq is the background 
fluorescence and F is the changes of fluorescence in the region of interest where 
cytoplasmic Ca2+ was increased.
2.5.2 Confocal imaging
The confocal images were taken on a Perkin Elmer, Nipkow disc-based UltraView 
confocal system linked to a fast digital camera and computer workstation running 
Ultra View LCI software attached to an Olympus inverted microscope. Images 
were aquired using x60 water-immersion objective lense (NA 1.2 at 20-50 frames
s'1)-
2.6 Determination of myosin light chain phosphorylation
2.6.1 Freezing apparatus
The freezing apparatus was designed by Dr T. Burdyga. As shown in Figure 2.3, it 
consists of a chamber containing six wells so that each well could be filled with 
different solutions. The chamber is fabricated from a block of Perspex that has 
been drilled to produce six large holes in a horizontal arrangement. Wells made of 
plastic were placed into each hole and glued into place to create a watertight seal. 
A series of tubes connected four of the holes so that with the aid of a pump, hot 
water could be circulated around the base of four wells of the wells to raise the
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temperature of the solution within the wells to the required experimental 
temperature (“a” in Figure 2.3A). The base of the chamber had four prongs in 
each comer over which springs were placed (“a” in Figure 2.3). The prongs 
slotted into four corresponding hollow cylinders mounted on the bottom of the 
chamber (“b” in Figure 2.3). This system allowed the freezing chamber to be 
lowered, moved along, and lifted back up by the user. On one side of the chamber 
was an open round shaped holder into which the glass container holding the 
pre-cooled acetone could be placed (“c” in Figure 2.3). This was made of metal to 
prevent any damage by acetone that may be spilt upon it.
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Figure 2.3 Diagram of apparatus designed to freeze the ureter. The freezing 
chamber showing the connections of tubes, electrodes and force transducer.
Figure designed by Dr S. Shabir.
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2.6.2 Freezing the ureter
Two ureters obtained from one animal were each cut into 3-4mm strips, giving 
approximately 16 pieces of ureter from each animal. The two ends of each strip of 
ureter were fitted with aluminium foil clips. One clip was attached to a fixed hook, 
and the other was attached to a force transducer (Grass FT03 force transducer, “a” 
in Figure 2.3). The strip of ureter was put in about 400pl bath solution in one well 
of the freezing chamber. The tissue can be sequentially immersed in different 
solutions moving from well to well by pushing down, moving along and releasing 
the chamber back up so that the tissue can be immersed in another solution 
contained in the next well. This method allows for a quick change of the solution 
bathing the ureter preparation.
The preparation can be frozen at any desired point of the force. The acetone was 
pre-cooled at -78°C, and then the tissue at any point of the force development was 
quickly immersed into the vessel of acetone and snap frozen. The time taken to 
transfer the preparation from the bath solution to acetone is about 200msec. The 
time taken for all of the phosphorylation in the muscle to be arrested ~2 0 0 msec 
(Maass-Moreno et al., 2001). The frozen point is recorded on the computer which 
is shown in Figure 2.3. Figure 2.4 shows a representative trace of force produced 
by a freezing preparation. Firstly, the ureter was immersed in a well containing 
Krebs solution and transferred to a well containing High K+ solution for 40 
seconds. It was then immersed in zero calcium solution for 80 seconds before 
being put into carbachol solution for 30 seconds and returned to the zero calcium 
solution. The protocol was also repeated after incubation in Krebs solution
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containing 5pM Ro320432 for 10 minutes. While in carbachol solution, the tissue 
generated force. At different points along the force development process, the 
tissue was quickly frozen in the pre-cooled acetone. Figure 2.4. shows 
representative trace during freezing. After the tissue was quickly frozen, the 
samples were transferred to eppendorfs containing a solution of acetone mixed 
with 5% (w/v) trichloroacetic acid and 20mM dithiothreitol (DTT) kept at -80°C 
by cooling in dry ice. All the samples were stored at -75°C in the freezer for at 
least 24 hours.
Figure 2.4 Typical trace during a freezing experiment. The force recorded during 
an experiment in which carbachol was used to stimulate the ureter. The left panel 
shows a control contraction when the tissue was frozen. The right panel shows the 
force produced when the tissue was frozen superimposed over the control force.
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2.6.3 Protein extraction
Samples were thawed at room temperature before use and the acetone solution 
was discarded. Then the samples were washed twice with 1ml of an acetone and 
20mM dithiothreitol solution to remove the trichloroacetic acid. The samples were 
washed by rotating for 30 minutes. Each strip of ureter was taken out of the 
eppendorf and the aluminium foil clips were removed from the ureter. Then each 
strip of ureter was placed in eppendorf tubes containing lOOpl of 9 M urea 
extraction buffer containing (mM): 20 DDT; 10 EGTA; 1 disodium EDTA; 5 NaF; 
10 phenylmethylsulfonyl fluoride; 2 Tris base; 2.1 glycine and 0.04% 
bromophenol blue. The eppendorfs were placed on a blood tube rotator and 
inverted for 1.5 hours. Every 15 minutes each eppendorf was vortexed for 15 
seconds. Then, the samples were centrifuged at 10,000g for 30 minutes. The 
samples were then used immediately or stored in the freezer (-20°C).
2.6.4 Electrophoresis
20pl of sample was loaded per lane and was resolved using a 3% acrylamide-urea 
stacking gel. The proteins were then separated on a 10% polyacrylamide-glycerol 
gel. The gel was run using Bio-Rad Protean II system for 30 minutes first at 10mA 
until the sample running through the stacking gel and then running at 16mA until 
30 minutes that the blue dye is about to exit the separating gel. The running buffer 
containing lOOmM glycine and 50mM Tris base and had a pH of 8.7. 250pl of 
2 -mercaptoethanol was added to the upper tank buffer after the samples were 
loaded.
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The protein was then transferred to a nitrocellulose paper running at 300mA for 1 
hour by using semi-dry transfer technique. The filter paper and nitrocellulose 
paper were soaked in semi-dry transfer buffer containing 25mM Tris-HCl, 
192mM glycine and 20% methanol at pH 8.3. After the protein transfer, the 
membranes were blocked in Tris-buffered saline containing 0.1% 
polyoxyethylenesorbitan monolaurate (Tween 20) at pH 7.6 (TBS-T) and 3% 
non-fat dry milk overnight at 4°C.
The next day the membrane was washed in TBS with 0.1% TWEEN 20 three 
times and each time for 5 minutes. The membrane was then incubated with 
monoclonal mouse anti-myosin light chain antibody (1:250) for 2 hours in TBS-T 
containingl% non-fat dry milk at room temperature. After washing with 5 times 
TBS-T 1% milk for 10 minutes each at room temperature, the membrane was then 
incubated with secondary biotin-conjugated anti-mouse antibody (1 :1 0 0 0 ) in 
TBS-T 1% milk for 40 minutes at room temperature, and then washed 3 times in 
TBS-T each time for 5 minutes. Then the membrane was incubated for 40 minutes 
with streptavidin-horseradish peroxidase conjugate (Amersham; 1:5000) and then 
washed in TBS-T twice for 10 minutes followed by one wash in TBS for 
lOminutes.
The membranes were incubated with Supersignal™ CL-HRP Substrate System 
(Pierce Chemical Co) for 5 minutes as described by the manufacturers, after 
which lumigrams of the western blots for non-phosphorylated and phosphorylated 
MLC20 were obtained by exposure to Amersham Hyperfilm™ECL™ and 
developing using Kodak developer and fixing solutions.
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Figure 2.5 Typical lumigrams of western blots. The non phosphorylated MLC20 
band is at the top and the mono-phosphorylated band P-MLC20 is shown at the 
bottom. The percentage o f MLC20 phosphorylation level can be calculated by 
the ratio o f the density o f the lower band to the total density o f both the lower and 
top bands.
2.6.5 Measurement and quantification of protein expression
Figure 2.5 shows a representative western blot obtained. The upper band shows 
the unphosphorylated myosin light chains and the bottom band shows 
phosphorylated myosin light chains. The percentage of myosin light chain 
phosphorylation level can be determined by the ratio of the density of the 
phosphorylated band to the sum of the densities of both phosphorylated and 
unphosphorylated bands, multiplied by 1 0 0  as following equation:
' density of phosphorylated band x 1 0 0
^(density of phosphorylated band + density of unphosphorylatedband)y
The density of each blots can be measured by scanning the blots with a Hewlett
Packard Scanjet 4C and the density of the bands measured using the Scion
software.
2.6.6 Analysis and statistics
The statistical significance of the results was measured using the appropriate t test.
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P values <0.05 were taken as statistically significant. One-Way ANOVA test was 
applied to test the significant difference (P<0.05) between different groups. Most 
of the results are given as a percentage of the control value unless otherwise stated 
in the individual chapters.
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Identification and investigation of functional role of PKC
in ureter smooth muscle
Chapter 3
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Identification and investigation of functional role of PKC in ureter 
smooth muscle
3.1 Introduction
PKC consists of a family of serine/threonine kinases with at least 12 members, 
grouped into three types-conventional, novel and atypical PKCs. Its distribution and 
function varies significantly in cells and tissues of different species. Overall PKC 
isoforms have different functional roles such as regulation of cell growth, apoptosis, 
ion channel activities and smooth muscle contractions (Rasmussen et al., 1987; 
Throckmorton et al., 1998; Gutcher et al., 2003; Barman et al., 2003). If PKC 
isoforms are to be considered as therapeutic targets for smooth muscle contraction 
disorder, it is important to know which isoforms are expressed by particular type of 
the smooth muscle. PKC a and e have been shown to express in guinea pig airway 
smooth muscle (Fatma, et al., 2001). The presence of PKC a, (3 and e has been 
demonstrated in rat skeletal muscle (Yamada, et al., 1995). In addition, PKC 8  has 
been found in rat brain and expressed exclusively in guinea pig gastrointestinal tract 
smooth muscle contributing to the control of tonic contraction (Garciam et al., 1993; 
Poole et al., 2003, 2006). PKC is involved in the regulation of contractile activity in a 
variety of smooth muscles (see Chapter 1). Activation of PKC causes hyperactive 
contractility of vascular smooth muscle, contributing to the development of
Chapter 3
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cardiovascular diseases (Salamanca & Khalil, 2005). Increased PKC activity in 
diabetic human penile tissue has also been reported (Angulo et al., 2006).
Phorbol ester (PDBu) is a widely used PKC activator. PKC activators have potent 
contractile effects on aortic smooth muscle (Jin et al., 2008). Activation of PKC 
increased excitability and altered patterns of gut motility (Horowitz et al., 1999). 
Certain phorbol ester act via PKC to decrease Ca2+ current via Ca2 channel (Doemer 
et al., 1990). PKC specific inhibitor Ro320432 has been widely used to investigate 
functional role of PKC. Enhanced PKC activity contributes to increased vascular 
reactivity in disease states. Therefore, PKC inhibitors may be potentially used as 
therapeutic agents to treat some of these disorders.
Rottlerin, also referred as mallotoxin, has been used as a PKC 8 specific inhibitor in 
some studies(Barman et al., 2006; Sakai et al., 2008) and has been used to identify the 
functional role of PKC 8 in control of contraction of pulmonary artery (Barman et 
al., 2004) and vascular smooth muscle cell migration (Kamiya et al., 2007). Studies 
also showed that rottlerin directly activated several types of K+ channels including 
BKCa channel (Zakharov et al., 2005).
In this study, we used immunohistochemistry and western blotting to identify the 
presence and distribution of several PKC isoforms in the guinea pig and rat ureter. In 
addition, we used PKC activator PDBu and inhibitor Ro320432 to investigate
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functional role of PKC in control of excitation-contraction coupling in ureter smooth 
muscle of both species by using different experimental protocols and modes of 
stimulation.
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3.2 Materials and methods
Simultaneous measurement of calcium and force
The simultaneous measurement of force and intracellular calcium were described in 
detail in Chapter 2.
Krebs solution was prepared as described in Chapter 2. The tissue was continuously 
perfused with Krebs, Krebs containing PDBu (0.1 pM) and Ro320432 (5pM).
The ureter smooth muscle was stimulated electrically at interval o f about 40 seconds 
to produce phasic contractions associated with Ca2+ transients by using Ag/AgCl 
electrodes placed in the bath solution with rectangular pulses (3-5V, 200ms).
Western blotting
The method of western blotting was described in detail in Chapter 2. Proteins were 
extracted from guinea pig and rat ureter muscle tissue in protease inhibitor solution 
containing RIPA buffer solution and after centrifuging at 10,000g for 10 minutes 
twice the supernatant was run on 4% polyacrylamide stacking gel then separated on a 
12% polyacrylamide gel. Then proteins were transferred to a PVDF membrane and 
were blocked in solution containing 5% non-fat milk powder overnight. Next day, the 
membrane was incubated with antibodies against PKC a, p, 5 and s for 1 hour at room 
temperature. After washing out the first antibodies, the membrane was incubated with
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secondary antibody for 1 hour. After washing out the secondary antibody, proteins 
were exposed to Hyperfilm ECL film (Amersham Biosciences) for 10 seconds to 5 
minutes and developed using a Kodak auto-developer (Kodak, Hemel Hempstead, 
UK).
Immunohistochemistry
The method of immunohistochemistry was described in detail in Chapter 2. Generally, 
the slides were incubated in xylene for 30 minutes at room temperature then followed 
by rehydration in a series of freshly made alcohol baths 100%, 95%, 85%, 70% and 
50%. Then the slides were placed in heated 0.01M citrate buffer and continued boiling 
for 1 2  minutes and was incubated with the dual endogenous enzyme block from 
DAKO kit for 20 minutes and washed in wash solution. The slides were then 
incubated with wash solution containing BSA albumin for 30 minutes. And then 
incubated with the primary antibody against PKCa, P, 8  and e overnight at 4°C. The 
slides were rinsed and then incubated with DAKO Envision Polymer and then 
exposed to DAB substrate for 10 minutes. Image was captured using Nikon 
MicrophotFX microscope fitted with a Nikon DXM1200 digital camera.
Chemicals
All chemicals were purchased from Sigma (Dorset, UK) except that PDBu and 
Ro320432 were purchased from Calbiochem.
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The stock solutions were prepared as following method: PDBu was dissolved in 
DMSO at a concentration of ImM. Ro320432 was dissolved in DMSO at a 
concentration of 5mM. The stock solution was diluted to the desired concentration 
with Krebs solution before starting the experiment.
Statistics
Data was analyzed with t-test, differences between means were assumed to be 
significant at P<0.05. One-Way ANOVA test was applied to test the significant 
difference (P<0.05) between different groups. All values represent mean ± s.e.m; n is 
the number of samples, each one from a different animal.
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3.3 Results
3.3.1 Expression and distribution of PKC isoforms in the guinea pig and rat 
ureter
This work is the first to identify expression and distribution of four PKC isofoms a, [3, 
8  and e in the guinea pig and rat ureter by using western blotting and 
immunohistochemistry. PKC a and p are conventional Ca2+-dependent PKC isoforms 
while PKC 5 and s are novel Ca2+-independent PKC isoforms. PKC isoforms a, P, 8  
and e have been identified by the bands with the molecular weight of about 84, 80, 78 
and 90 kD, respectively. Western blotting shows that conventional PKC a and P are 
present in both guinea pig and rat ureteric extracts. PKC 8  is found in the guinea pig 
but not rat ureter (Figure 3.1 and 3.2). PKC s has not been found in ureter of both 
species. Positive control from skeletal smooth muscle, airway smooth muscle and 
brain from both animals have been used to check validity of our findings. Negative 
control has also been used to show the evidence of non-specific binding. The 
expression pattern is shown in Figure 3.1 and 3.2.
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Immunohistochemistry analysis of the PKC isofom was performed on guinea pig and 
rat ureteric tissue samples. The localization of PKC a, P, 5 and e was studied on fixed 
ureteric sections of both guinea pig and rat ureter.
Conventional PKC a was found in both smooth muscle and urothelium. Figure 3.1 
and 3 . 2  show that it was more abundant in the urothelium of both species. 
Conventional PKC p was localized in smooth muscle and urothelium of the guinea 
pig ureter while in rat ureter it was confined exclusively to urothelium. Novel PKC 5 
was abundant in the guinea pig ureteric smooth muscle but not urothelium, while in 
the rat ureter it was not found at all (Figure 3.2). Novel PKC £ was completely absent 
in the ureter of both species. Negative control does not show any evidence of 
non-specific binding due to the secondary antibody and its enzyme conjugate. The 
summary of PKC isoform expression and distribution in the guinea pig and rat ureter 
is shown in Table 3.1. The immunohistochemistry data of both guinea pig and rat 
ureter are consistent with the western blotting results. However, collectively data 
obtained indicate that although PKC P was detected by western blotting analysis in 
both guinea pig and rat ureteric extracts, the immunohistochemistry analysis shows 
that this PKC isoform is only present in rat urothelium but not in smooth muscle 
suggesting that it can not be directly involved in control of rat ureter smooth muscle 
contractility.
3.3.2 Distribution of PKC isoforms in guinea pig and rat ureter
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In the next set of experiment, the functional role of PKC was investigated by studying 
the effects of PKC activator PDBu and PKC inhibitor Ro320432 on phasic 
contraction and Ca2+ transients in the guinea pig and rat ureter evoked by EFS.
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Figure 3.1 The expression and distribution o f PKC isoforms in guinea pig ureter. 
(A-D) Western blots (top panel) and immunostaining of sections o f ureter (bottom 
panel) showing expression and distribution o f PKC isoforms a, [3, 8  and s in the 
guinea pig ureter. Ur is urothelium, SM is smooth muscle cell.
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Figure 3.2 The expression and distribution of PKC isoforms in rat ureter. (A-D) 
Western blots (top panel) and immunostaining o f sections of ureter (bottom panel) 
showing expression and distribution of PKC isoforms a, P, 8  and e in the rat ureter. Ur 
is urothelium, SM is smooth muscle cell.
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Table 1. The distribution of PKC isoforms a, p, 8 and £ in guinea pig
and rat ureteric tissues
89
3.3.3 The effects of PKC activator PDBu and PKC inhibitor Ro320432 on phasic 
contraction and Ca2+ transients in the guinea pig and rat ureteric smooth muscle 
evoked by EFS; Evidence for species dependence
In this set of experiments, the effect of direct activation and inhibition of PKC on 
phasic contraction and Ca2+ transients evoked by EFS have been studied in the guinea 
pig and rat ureteric smooth muscle loaded with Indo-1 .
PDBu at concentration of 0.1 pM was used in all experiments. PKC inhibitor 
Ro320432 was used in concentration of 5pM.
EFS of ureteric strips at about 40 second intervals produced a regular pattern of phasic 
contractions associated with Ca2+ transients in ureter smooth muscle of both species 
(Figure 3.3). Addition of PDBu produced stimulant effect on phasic contractions in 
both guinea pig and rat ureteric smooth muscle (Figure 3.3). In rat ureter a gradual 
rise in the baseline of force was also seen which despite the presence of PDBu was 
fully relaxed upon termination of stimulation (Figure 3.3 B). As can be seen from 
superimposed records of Ca2+ transients and force shown in Figure 3.4A, an increase 
in the amplitude of phasic contractions in the guinea pig ureter was associated mainly 
with an increase in the duration of the Ca2+ transients (1.3 ± 0.05 times, n=20) 
(p<0.05). In contrast, in the rat ureter an increase in the amplitude of force was not 
associated with any significant changes of the parameters of the Ca2+ transients
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(Figure 3.4 B). The effects of PDBu on ureter smooth muscle were fully reversed by
PKC inhibitor Ro320432 (Figure 3.3), which on its own had no effects on Ca2’ and
2+
force in ureteric muscle of both species (data not shown). Normalized traces of Ca 
transients and force obtained in the absence and presence of PDBu clearly indicate 
that in the guinea pig ureter stimulant action of PDBu on force is caused by an 
increase in the duration of the Ca2+ transient (Figure 3.4 A) while in rat ureter it was 
Ca2+-independent (Figure 3.4 B). The fact that in the rat ureter the relaxation phase of 
the phasic contraction was slowed down with no change in the kinetics of the 
relaxation of the Ca2+ transient suggests that the stimulant action of PDBu in rat ureter 
is Ca2+ independent and is likely to involve in Ca2 sensitization mechanism. 
Ca2+-independent elevation of baseline of force unaccompanied by changes in 
baseline [Ca2+]i which fully relaxes on termination of stimulation (Figure 3.3 B) also 
suggests Ca2+-independence mechanism of gradual build up of baseline force due to 
incomplete relaxation produced by each preceding phasic contraction in the rat 
ureteric smooth muscle. PKC inhibitor Ro320432 and PKC 8  specific inhibitor 
rottlerin (data not shown) fully reversed stimulant action of PDBu in the ureter of both 
species (Figure 3.3). These data suggest that at least in ureteric smooth muscle 
rottlerin acts as a non-specific PKC 8  inhibitor. This finding is consistent with some 
recent studies (Soltoff, 2007).
These data collectively indicate that guinea pig and rat ureter express different 
isoforms of PKC and respond differently to PKC stimulation by PDBu.
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Figure 3.3 The effect of PKC activator PDBu and PKC inhibitor Ro320432 on Ca2 transients 
and phasic contractions evoked by EFS in guinea pig and rat ureter smooth muscle. In this and all 
other figures bottom trace (red) shows change in [Ca2+]; and top trace (black) represents force.
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A. Guinea pig ureter
B. Rat ureter 
a b c
Figure 3.4 The effect of PKC activator PDBu on Ca2+ transients and phasic contractions evoked 
by EFS in guinea pig and rat ureter smooth muscle. Aa, Ba- independent Ca transients and 
phasic contractions of guinea pig and rat ureter smooth muscle in the absence and presence of 
PDBu, respectively. Ab, Bb- superimposed records from Aa and Ba. Ac and Be- superimposed 
relaxation phase of force and Ca2+ transient from Ab and Bb. In this figure, traces in red are 
records obtained in the presence of PDBu; traces in black are controls. Note the relaxation phase 
of rat ureter phasic contraction is slowed down by PDBu with no change of Ca .
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3.4 Discussion
The increase in [Ca2+]i is required for activation of smooth muscle contraction. The 
relationship between [Ca2+]i and force has been well established in ureter (Burdyga & 
Wray, 1999). There is a marked hysteresis between [Ca2+]i and force, i.e. Ca2+ rises 
and peaks before force; there is no steady state between [Ca2 ]i and force during 
development of the phasic contraction. Thus, the duration of the Ca2 transients plays 
a key role in control of the amplitude of phasic contraction (Burdyga & Wray, 1999). 
The longer the duration of Ca2+ transients, the higher is the amplitude of force. It 
suggests that equilibrium between Ca2+ transient and contractile element during the 
development of the phasic contraction is not reached.
PKC activator PDBu increased the amplitude and duration of phasic contraction 
evoked by EFS in both guinea pig and rat ureter smooth muscle. PKC specific 
inhibitor Ro320432 could fully reverse the stimulant effects of PDBu on ureters of 
both species. In the guinea pig ureter an increase in the amplitude and duration of 
phasic contraction was caused mainly by an increase in the duration of the Ca 
transient while in rat ureter it was Ca2+-independent.
In rat ureter, activation of PKC is involved in regulation of relaxation phase of phasic 
contraction by prolonging the relaxation time of the phasic contraction without any 
significant changes in the kinetics of intracellular [Ca2+]i. In other words, PKC is
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modulating smooth muscle contraction in a Ca2+-independent manner. This suggests 
that the major role of PKC in rat ureter smooth muscle contraction is modulation of 
Ca2+ sensitization by affecting the activity of MLCP. In the guinea pig ureter, 
Ro320432 at 5pM could reverse the stimulant effect of PKC and bring the parameter 
of force and Ca2+ to control level which proves it to be a potent and efficient PKC 
inhibitor in both guinea pig and rat ureter as reported by others in other types of 
smooth muscle (Mauro et al., 2002; Kim et al., 2004).
Thus, there are two species dependent mechanisms involved in modulation of force 
by PKC in ureter smooth muscle. Based on difference in PKC isoforms expression 
between the two species, one can suggest that in the guinea pig ureter smooth muscle 
PKC P and 8  are more functionally important. One of these or both isoforms might be 
involved in modulation of the duration of the Ca2+ transient which underlies the 
increase in the amplitude of force. In contrast, rat ureter smooth muscle mainly 
express PKC a isoform which is likely to be involved in modulation of force in 
Ca2+-independent manner by inhibiting MLCP activity as was reported for some other 
types of smooth muscles (Li et al., 1998; Webb et al., 2000; Hai et al., 2002). Possible 
role of other PKC isoforms which were not investigated in this study may contribute 
to regulation of the force-Ca2+ relationship in ureteric smooth muscle can not be 
excluded.
In conclusion, we are the first to examine the expression and distribution of PKC
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isoform in guinea pig and rat ureter by using western blotting and 
immunohistochemistry. We also found for the first time that PKC activator PDBu 
could increase the amplitude and duration of force and duration of Ca transient in 
the guinea pig ureteric smooth muscle and an increase the amplitude and duration of 
force without changes of [Ca2+]i in the smooth muscle of the rat ureter. PKC inhibitor 
Ro320432 reversed the stimulant effects of PDBu in the ureteric smooth muscle of 
both species. It shows Ca2+-dependent mechanism in the guinea pig ureter and 
Ca2+-independent mechanism in the rat ureter.
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Mechanism of the stimulant action of PKC activation in the 
guinea pig ureter smooth muscle
Chapter 4
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Mechanism of the stimulant action of PKC activation in the guinea 
pig ureter smooth muscle
4.1 Introduction
2+
According to literature, PKC can produce stimulant action via inhibiting Ca 
sparks/STOCs coupling mechanism in vascular smooth muscle (Bonev et al., 1997). 
Ca2+ sparks is spontaneous transient localized Ca2+ release from the SR via a cluster 
of ryanodine-sensitive Ca2+ release channels (RyR). Depending on the types of 
smooth muscle, Ca2+ sparks can activate BKca channel on the plasma membrane to 
generate STOCs, Ca2+-activated Cf channels to generate STICs or both populations of 
channels to generate STOICs (Nelson et al., 1995; Bonev et al., 1997; Jaggar et al., 
1998; Porter et a l, 1998). BKCa channels have been shown to be involved in control 
of cell excitability in various types of smooth muscle such as human cerebral arteries 
(Wellman et al., 2002), guinea pig urinary bladder (Heppner et al., 1997) and guinea 
pig ureter (Burdyga & Wray, 2005).
BKCa channels can be blocked by charybdotoxin and iberiotoxin and by 
tetraethylammonium(TEA) in low concentration. Inhibition of the SR Ca2 release by 
ryanodine or CPA can abolish both calcium sparks and STOCs, causing cell 
membrane depolarization (Nelson et al., 1995).
Chapter 4
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STOCs, is responsible for repolarizing phase of the action potential and can contribute 
to the resting membrane potential (Imaizumi et al., 1996; Heppner et al., 1997). 
Activation of STOCs by Ca2+ sparks could hyperpolarize cell membrane and close the
voltage-dependant Ca2+ channels (Bryden & Nelson, 1992; Knot & Nelson, 1998,
2+
Knot et al., 1998). Unlike cardiac and skeletal muscle, in smooth muscle the Ca 
sparks can indirectly modulate the membrane potential and cause smooth muscle 
relaxation via activation of the Ca2+ sparks/STOCs coupling mechanism. Recent study 
shows that in guinea pig ureter smooth muscle Ca2+ sparks/STOCs coupling 
mechanism is present and can act as a negative feedback mechanism to control the 
excitability of the ureteric smooth muscle. Ca2+ sparks/STOCs coupling mechanism 
plays an important role in setting the refractory period (Burdyga & Wray, 2005) and 
duration of the plateau component of the action potential (Borisova et al., 2007).
In vascular smooth muscle, activation of PKC could inhibit BKca channel (Minami et 
al., 1993; Schubert et al., 1999; Crozatier, 2006; Ledoux et al., 2006). BKCachannel 
can be activated by some vasodilators via activation of PKC (Song & Simard, 1995; 
Standen & Quayle, 1998). The a-subunit of BKca channel can be phosphorylated by 
cAMP-dependent PKA (Tian et al., 2001; Zhou et al., 2001) and PKC (Reinhart et al., 
1995). RACK, a scaffolding protein of PKC, is shown to be a BKCa channel binding 
protein (Isacson et al., 2007). In cerebral arteries, activation of PKC decreased the 
frequency of both Ca2+ sparks and STOCs therefore inhibiting BKca channel activity 
indirectly (Bonev et al., 1997). Inhibition of PKC was also shown to inhibit Ca2+
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sparks in airway smooth muscle (Liu et al., 2007).
Ca2+ sparks/STOCs coupling mechanism is known to play a negative feedback 
mechanism to control the smooth muscle excitability. Is Ca2+ sparks/STOCs coupling
mechanism involved in the stimulant action of PKC in the guinea pig ureteric smooth
2+
muscle? To answer this question, we have investigated possible role of Ca 
sparks/STOCs coupling mechanism in stimulant action of PDBu in the guinea pig 
ureteric smooth muscle. We have investigated the effects of PDBu on action potential, 
Ca2+ transients and force to prove that an increase in duration of the Ca2+ transient by 
PDBu was indeed associated with the prolongation of the plateau component of the 
action potential. Secondly we have investigated the effects of PDBu on Ca transients 
and force evoked by EFS in the presence of TEA to block BKca channels and CPA to 
block Ca2+ sparks. Thirdly, we have investigated the effects of PDBu on Ca2+ sparks 
using confocal imaging of guinea pig ureteric myocites.
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4.2 Materials and Methods
Simultaneous measurement of calcium and Force
The simultaneous measurement of force and intracellular calcium were described in 
Chapter 2.
Confocal imaging of Fluo-4 loaded ureteric cells was performed using Ultra View 
Nipkow disc based imaging system.
Krebs solution was prepared as described in Chapter 2. The tissue was continuously 
perfused with Krebs, Krebs containing CPA (20pM), TEA (lOmM), PDBu (0.1 pM) 
and caffeine (ImM).
The ureter smooth muscle were stimulated electrically at interval of about 40 seconds 
to produce phasic contraction associate with Ca2+ transients by using Ag/AgCl 
electrodes placed in the bath with rectangular pulses (3-5V, 2 0 0 ms).
Chemicals
All chemicals were purchased from Sigma (Dorset, UK), unless otherwise stated. 
PDBu was purchased from Calbiochem.
The stock solutions were prepared as following method: PDBu was dissolved in 
DMSO at a concentration of ImM. CPA was dissolved in ethanol at a concentration of
101
20 mM. The stock solutions were diluted to the desired concentrations with Krebs
solution before starting the experiment.
Statistics
Data was analysed with t-test; differences between means were assumed to be 
significant at P<0.05. One-Way ANOVA test was applied to test the significant 
difference (P<0.05) between different groups. All values represent mean ± s.e.m; n is 
the number of samples, each one from a different animal.
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4.3 Results
4.3.1 Effects of PKC activator PDBu on action potential, calcium transients and 
phasic contractions in the guinea pig ureteric smooth muscle
Using double sucrose gap method combined with photometric measurement of [Ca"+]i 
and force in Indo-1 loaded strips of the guinea pig ureter the effects of PDBu on the 
action potential, Ca2+ transients and force were recorded simultaneously. The ureteric 
strips were stimulated by short (100m sec) suprathershold depolarizing pulses. Figure
4.1 shows that PDBu produced prolongation of the plateau component of the action 
potential which was associated with an increase in the duration of the Ca transient 
and the amplitude and duration of the phasic contraction. These data clearly indicate 
that changes in the duration of the Ca2+ transients and force produced by PDBu 
described in Chapter 3 were associated with an increase in the duration of the plateau 
component of the action potential. The increase in duration of the plateau component 
of the action potential can be produced by either inhibition of Ca2+ sparks or BKca 
channels (Borisova et al., 2007). Since both mechanisms were reported to be inhibited 
by PKC at least in some types of smooth muscle (see introduction of this chapter). We 
next investigated the effects of PDBu on Ca2+ transients and force evoked by EFS in 
the presence of TEA or CPA.
103
Control PDBU
2.2
Force
(mN)
0 . 0  
1.2 
F 400/500
1.0
15
mV
0
Figure 4.1 Simultaneous records of action potential (bottom trace), calcium transients 
(middle trace) and phasic contractions (top trace) in the absence and presence of 
PDBu (0.1 pM). (Dr. T. Burdyga, unpublished data).
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4.3.2 Effects of PDBu on calcium transients and phasic contractions evoked by 
EFS in the presence of TEA
Tetraethylammonium(TEA) at concentration of lOmM was used to block the 
Ca2+-activated K+ (BKCa) channels in guinea pig ureteric smooth muscle.
Figure 4.2 shows typical record of changes in Ca2+ transients and force evoked by 
EFS in the presence of TEA and combined action of TEA and PDBu. This figure
shows that TEA produced an increase in the amplitude and duration of the phasic
2+contraction which was mainly associated with an increase in the duration of the Ca
transient (Figure 4.3). PDBu produced marked increase in the amplitude but
2+
especially duration of the phasic contraction although the amplitude of the Ca 
transients in the presence of TEA and PDBu was reduced (Figure 4.2 and 4.3). These 
data strongly suggest that stimulant action of PDBu in the guinea pig ureter smooth 
muscle does not involve inhibition of BKca channels. In fact the data obtained suggest 
that the stimulant action of PDBu in the presence of TEA was potentiated.
Thus, PDBu increased the amplitude of force 1.9 ± 0.1 times and duration of force 
and Ca2+ transient in the presence of TEA 6.2 ±0.1 times and 12.2 ± 0.06 times 
compared to control, respectively (n=10) (P<0.05). This increase in the duration of 
Ca2+ transient and force in the presence of TEA was associated with an increase in the
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duration of the plateau component of the action potential (Figure 4.4).
These data collectively suggest that BKCa channels are not inhibited by PKC 
activation in the guinea pig ureteric smooth muscle.
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Figure 4.2 The effect o f PDBu on Ca and phasic contractions evoked by EFS in
guinea pig ureter smooth muscle in the presence o f TEA. (A) Original trace shows
2+
Ca transients and phasic contraction recorded under control condition, in the
presence o f TEA and TEA with PDBu; (B) Extracted trace from (A) shows individual
2+ . . . .
Ca transients and phasic contraction in guinea pig ureter smooth muscle.
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Figure 4.3 Mean values o f amplitude (A) and duration (B) of force and amplitude (C) 
and duration (D) o f Ca2+ transients in the absence and presence of TEA and in the
presence o f TEA with PDBu and expressed as percentage of control.
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Figure 4.4 The effect o f PDBu on the action potential, Ca2+ transients and phasic 
contraction in guinea pig ureter smooth muscle in the presence o f TEA (lOmM) and 
TEA with PDBu. (Dr. T. Burdyga, unpublished data).
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4.3.3 Effects of PDBu on calcium transients and phasic contractions evoked by 
EFS in the presence of CPA
In this study, cyclopiazonic acid (CPA), a selective blocker of the SR Ca -ATPase, 
was used to block the SR function and deplete the SR Ca2+ store to inhibit Ca2+ sparks. 
In previous studies, it was found that treatment of guinea pig ureter smooth muscle 
with CPA at concentration of 20 pM was optimal to completely deplete the SR and 
abolish Ca2+ sparks (Burdyga et al., 1995).
Figure 4.5 shows that CPA increased the baseline level of Ca“ and an increase in the 
amplitude and duration of the force 2.3 ± 0.27 times and 1.5 ± 0.2 times (n=12) 
(P<0.05) compared to control, respectively. This increase in amplitude of force was 
accompanied by an increase in the duration of the Ca2 transient 1.5 ± 0.2 times of 
control (n=12) (PO.05) (Figure 4.6).
In the presence of CPA, PDBu still showed marked stimulant effect on both force and 
Ca2+ transient. In the presence of CPA, PDBu increased the amplitude and duration of 
the force which was accompanied by the increase in duration of the Ca transients 
(Figure 4.5 and 4.6).
Thus, the data obtained in this study strongly suggest that an increase in duration of 
the Ca2+ transient by PDBu in the guinea pig ureteric smooth muscle was not
no
associated with possible inhibition of Ca2+ sparks. In fact, stimulant action of PDBu 
on the amplitude and especially duration of force in the presence of CPA were 
enhanced (Figure 4.5 and 4.6).
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2+Figure 4.5 The effect o f PDBu on Ca transient and phasic contractions evoked by
EFS in guinea pig ureter smooth muscle in the presence o f CPA. (A) Original trace 
shows Ca2+ transients and phasic contraction recorded under control condition, in the 
presence o f CPA and CPA with PDBu; (B) Extracted trace from (A) shows individual
Ca2+ transients and phasic contraction in guinea pig ureter smooth muscle.
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Figure 4.6 Mean values of amplitude (A) and duration (B) of force and amplitude (C ) 
and duration (D) of Ca2+ transients in the absence and presence of CPA and in the
presence of CPA with PDBu and expressed as percentage of control.
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4.3.4 Effect of PDBu on Ca2+ sparks
In order to investigate whether PKC activation blocks Ca2+ sparks in the guinea pig 
ureteric myocytes, the effects of PDBu on spontaneous Ca2+ sparks of isolated ureteric 
smooth muscle cells have been investigated. We have found that PDBu when applied 
to ureteric cells showing the presence of spontaneous Ca2+ sparks was not abolished 
by PDBu. In fact, it can be seen from Figure 4.7, PDBu produced an increase in the 
amplitude and frequency of spontaneous Ca2+ sparks. Again, these data strongly 
suggest that stimulant action of PDBu in guinea pig ureteric smooth muscle was not 
associated with direct inhibition of Ca2+ sparks.
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Figure 4.7. Effects of PDBu on spontaneous Ca2+ sparks in isolated guinea pig 
ureteric myocites. A- Stack of images showing sptemporal and spatial characteristics 
of spontaneous Ca2+ spark. B- changes in fluorescence signals in the discharging 
(Reg.l) and non-discharging (Reg.2) sites in the absence and presence of PDBu (10 
minutes).
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4.3.5 Effects of PDBu on calcium transients and phasic contractions evoked by 
EFS in the presence of caffeine
Caffeine can activate Ca2+ induced Ca2+ release (CICR) by sensitizing RyR to Ca2+. It 
has been shown that in the guinea pig ureter caffeine at low concentration can 
increase Ca2+ sparks activity in smooth muscle to activate Ca2+ sparks/ STOCs 
coupling mechanism leading to inhibition of action potential (Borisova et al., 2007).
2 d "Caffeine at low concentration (ImM) was shown to have no effect on either Ca 
current or Ca2+ transients in voltage clamped ureteric myocytes (Borisova et al., 2007). 
Caffeine (ImM) produced an inhibitory effect on force and Ca2+ transients evoked by 
EFS in the guinea pig ureteric smooth muscle (Figure 4.8 and 4.9).
Stimulant action of PDBu under conditions when Ca2+ sparks/STOCs coupling
mechanism was maximized by caffeine was significantly decreased suggesting that
2+
activation of PKC in the guinea pig ureter does not involve inhibition of Ca 
sparks/STOCs coupling mechanism.
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Figure 4.8 The effect of PDBu on Ca 2+ transients and phasic contractions evoked by 
EFS in guinea pig ureter smooth muscle in the presence of caffeine (lpM). (A) 
Original trace shows Ca 2+ transients and phasic contraction recorded under control 
condition, in the presence of caffeine and caffeine with PDBu; (B) Extracted trace 
from (A) shows individual Ca2+ transients and phasic contraction in guinea pig ureter 
smooth muscle.
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Figure 4.9 Mean values of amplitude (A) and duration (B) of force and amplitude (C)
2+and duration (D) of Ca transients in the absence and presence of caffeine and in the 
presence of caffeine with PDBu and expressed as percentage of control.
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4.4 Discussion
PKC activator PDBu significantly prolonged the duration of the plateau component of 
action potential in guinea pig ureteric smooth muscle. This effect on the action 
potential can be achieved either by activation of L-type Ca2' channels or inhibition of 
BKca channels or combination of both.
Ca2+ sparks/ STOCs coupling mechanism plays a key role in control of refractory
period in the guinea pig ureteric smooth muscle. If Ca2+ sparks or STOCs were
2+
blocked, the refractory period disappeared (Burdyga & Wray, 2005). In addition, Ca 
sparks/ STOCs coupling mechanism plays an important role in control of the duration 
of the complex action potential in guinea pig ureteric smooth muscle (Burdyga & 
Wray, 1999; Borisova et al., 2007). Inhibition of Ca2+ sparks or STOCs by CPA and 
TEA, respectively, produced stimulant effect on guinea pig ureteric smooth muscle by 
increasing the plateau component of the action potential. CPA is shown to completely 
disable the SR function therefore Ca2+ failed to load into SR resulting in the elevation 
of the intracellular Ca2+ concentration which could explain the elevation of the 
baseline of [Ca2+]i produced by CPA in this study. In the present study we showed that 
in the presence of CPA or TEA PDBu still produced prominent stimulant effect on 
Ca2+ transients and phasic contractions evoked by EFS in the guinea pig ureteric 
smooth muscle.suggesting that Ca2+ sparks/STOCs coupling mechanism is unlikely to 
be involved in the stimulant action of PDBu. The data with TEA also suggest that
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direct effects of PKC activation on BKca channels are also unlikely.
Caffeine, as an activator of CICR, has been shown to decrease the duration of the 
plateau component of the action potential associated with maximal activation of Ca 
sparks/STOCs coupling mechanism in the guinea pig ureter (Borisova et al., 2007). 
This effect of caffeine in the guinea pig ureteric smooth muscle is in contrast to its 
stimulant effect seen in cardiac muscle (O’Neil et al., 1990). In the presence of low 
concentration of caffeine, stimulant action of PDBu was diminished, suggesting that 
inhibitory effect of caffeine via Ca2+sparks/STOCs coupling mechanism is not 
inhibited by activation of PKC.
The results obtained show that activation of PKC increased Ca2* spark frequency in 
the guinea pig isolated ureteric smooth muscle cells. This may be due to the direct 
action of PKC on the RyRs (Takasago et al., 1991). In cerebral arteries, activation of 
PKC decreased Ca2+ sparks frequency through a direct action on RyRs (Bonev et al., 
1997). However, in rabbit portal vein, activation of PKC inhibited BKca channels 
directly but not via Ca2+ sparks (Kitamura et al., 1992). In this study we showed that 
PDBu produced stimulant rather than inhibitory effects on Ca sparks. Since in the 
guinea pig ureter smooth muscle, Ca2+ sparks activate BKca channels, generating 
STOCs (Burdyga & Wray, 2005). Therefore, by exerting the stimulant action on Ca2+ 
sparks, PDBu could be able to increase the BKca channels activity therefore 
enhancing STOCs and Ca2+ sparks/STOCs coupling mechanism. One could expect
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that PDBu could have produced inhibitory rather than stimulant effects on Ca2+ 
transients and force. Stimulant effect of PDBu on Ca2+ sparks activity could be 
expected to decrease the duration of action potential and Ca2+ transient. The fact that 
stimulant action of PDBu on duration of Ca2+ transient in the presence of either TEA 
or CPA was stronger comparing to control conditions suggests that PDBu could 
indeed stimulate Ca2+sparks/STOCs coupling mechanism along with much stronger 
effects on the inward currents which results in the overall stimulant action.
In conclusion, we are the first to provide the evidence that activation of PKC 
increases Ca2+ sparks frequency in guinea pig ureteric smooth muscle. PKC activator 
PDBu could increase the amplitude and duration of force and Ca2+ in the presence of 
CPA and TEA, which could be explained that activation of PKC has no inhibitory 
effect on the Ca2+ sparks/STOCs coupling mechanism.
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Chapter 5
PKC activation and Na+-dependent mechanisms in guinea
pig ureter
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Chapter 5
PKC activation and Na+-dependent mechanisms in guinea 
pig ureter
5.1 Introduction
Na+ has been shown to play an important role in control of smooth muscle 
excitation-contraction coupling (Branding et al., 1990). The regulation of Na+ in 
smooth muscle cells can involve Na+-K+ pump or Na+-Ca2+ exchanger. Currently, 
there is no direct evidence of inward Na+ current in guinea pig ureter smooth muscle. 
In addition, application of tetrodotoxin (TTX) which is a potent inhibitor of 
voltage-dependent Na+ channel in other muscle tissues, does not have effect on either 
inward currents or action potential in guinea pig ureter (Kuriyama et al., 1967; Sui et 
al., 1997). Therefore, it is suggested that there is no TTX-sensitive voltage gated Na+ 
channel in this tissue. Furthermore, removal of extracellular Na+ has no effect on 
currents carried by other ions (Sui et al., 1997).
In guinea pig ureter, the action potential is known to consist of a spike component and 
a long lasting plateau component. Both Na+ and Ca2+ can contribute to maintain the 
duration of the plateau component of action potential (Shuba, 1977(2)). It is known 
that Ca2+ carries predominantly the inward current in this tissue. No inward Na+ 
current was found in guinea pig ureteric myocites (Sui et al., 1997). The evidence for 
Na -Ca exchanger has been obtained for guinea pig ureter (Aickin et al., 1984;
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1987). Normally, Na+-Ca2+ exchanger extrudes one Ca2+ out of cell in exchange of 
three Na+ into the cell. Therefore, it is electrogenic and can affect the membrane 
potential. The direction of movement of these ions depends upon the membrane 
potential and the chemical gradient for Ca2+ and Na+. Under certain condition, for 
example, after inhibition of Na+-K+ pump by ouabain, the exchanger begins to operate 
in “Ca2+ entry mode” (Aickin et al., 1984). However, there is evidence that Na+-Ca2+ 
exchanger can also operate in normal physiological conditions. Aaronson et al. has 
shown that Na+-Ca2+ exchanger in single voltage clamped guinea pig ureteric myocyte 
can be involved in control of Ca2+ signaling in physiological range of [Na+]i 
(Aaronson et al., 1989). In addition, by using the SBFI- fluorescent Na+-sensitive 
indicator to measure [Na+]j, Lamont et al. provided further evidence of Na+-Ca2+ 
exchanger and its role in modulating the force contraction in guinea pig ureter 
(Lamont et al., 1998). In accordance with literature, PKC can modulate activity of 
Na+-Ca2+ exchanger. In vascular smooth muscle cells of conduit arteries such as aorta 
(Mashibum et al., 1997) and small renal arterioles (Khoyi et al., 1991) stimulant 
action of PKC activation was associated with activation of the Na+-Ca2+ exchanger 
(Fowler et al., 1996). Therefore in the next series of experiments we have studied 
possible role of Na+-Ca2+ exchanger in the stimulant action of PDBu in the guinea pig 
ureter. This is achieved by measuring force and calcium simultaneously induced by 
activation of the Na+-Ca2 ’ exchanger in “Ca2+ entry” mode in Na+ loaded guinea pig 
ureteric muscle as described earlier (Aickin et al., 1984; Lamount et al., 1998).
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5.2 Materials and Methods
Simultaneous measurement of calcium and Force
The measurement of force and intracellular calcium were described in Chapter 2.
Krebs solution was prepared as described in Chapter 2. The tissue was continuously 
perfused with Krebs solution. Ouabain (1CT4 M) was used to inhibit Na+-K+ pump for 
1 hour to produce Na+ loading ureteric tissue. Na+-free (Tris substitution) was used to 
stimulate the ureteric strips loaded with Na+ to activate Na+-Ca2+ exchanger in Ca2+ 
entry mode.
The ureteric smooth muscle was stimulated electrically at interval of about 40 seconds 
to produce phasic contraction associate with Ca2+ transients by using Ag/AgCl 
electrodes placed in the bath with rectangular pulses (3-5V, 200ms).
Chemicals
All chemicals were purchased from Sigma (Dorset, UK), unless otherwise stated. 
PDBu was purchased from Calbiochem.
The stock solutions were prepared as following method: PDBu was dissolved in 
DMSO at a concentration of ImM. The stock solutions were diluted to the desired 
concentrations with Krebs solution before starting the experiment.
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Statistics
Data was analysed with t-test; differences between means were assumed to be 
significant at P<0.05. One-Way ANOVA test was applied to test the significant 
difference (P<0.05) between different groups. All values represent mean ± s.e.m; n is 
the number of samples, each one from a different animal.
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5.3 Results
5.3.1 Effects of PDBu on force and calcium evoked by EFS in the absence of 
extracellular Na+
Removal of extracellular Na+ shortened the duration of plateau component of the 
action potential in guinea pig ureter smooth muscle (Shuba, 1977 (2)). Hence, it was 
suggested that the extracellular Na+ is important for generation of the plateau 
component of the action potential. Therefore, the effects of PKC activator PDBu on 
Ca2+ and force evoked by EFS in the guinea pig ureter smooth muscle in Na+ free 
solution were investigated next.
In this experiments ureteric strips were stimulated by electrical field stimulation at 
about 40 seconds intervals to obtain a regular pattern of phasic contractions associated 
with Ca2+ transients. Removal of Na+ from the bathing solution produced a rapid 
inhibitory effect on both force and Ca2+ in guinea pig ureter within 1 minute (Figure 
5.1). Addition of PDBu (0.1 pM) to Na+-itee solution produced partial restoration of 
Ca2+ and force (Figure 5.1 A). As can be seen from Figure 5.1 B and Figure 5.2, in 
Na+ free solution, the amplitude of Ca2+ transients and force was significantly reduced 
(n=7). PDBu when applied in Na+-free solution produced significant restoration of the 
amplitude of both Ca2+ transients and force (Figure 5.1 and 5.2).
The data obtained clearly show that PDBu still has strong stimulant effect on Ca2+ and
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force in the absence of extracellular Na+ suggesting that Na+ sensitive mechanisms 
controlling the duration of the plateau component of action potential are not involved 
in the stimulant action of PKC activation in the guinea pig ureter smooth muscle.
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5 mins
B
2+Figure 5.1 The effect o f PDBu on Ca transients and phasic contractions evoked by 
EFS in Na+-free solution in the guinea pig ureter smooth muscle. A- Ca transients 
and phasic contraction evoked by EFS in normal Krebs, Na -free solution and PDBu 
(0.1 pM) applied in Na+ -free solution. B- Extracted single traces o f Ca transients 
and force recorded under control condition, in Na -free solution and in the presence of
PDBu added to Na+-free solution.
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Figure 5.2 Restoration o f the amplitude o f force (A) and Ca transients (B) by PDBu 
applied in Na -free solution. The amplitude of force and C a  transients under control 
conditions were taken for 100%.
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5.3.2 Effects of PDBu on the force and Ca2+ induced by Na+-free solution in the 
Na+-loaded guinea pig ureter smooth muscle
To investigate if Na+-Ca2+ exchanger activity in guinea pig ureter smooth muscle is 
modulated by PKC, the effect of PKC activator PDBu on the Ca2+ and force induced 
by Na+-ffee solution in the Na+-loaded guinea pig ureter smooth muscle has been 
studied.
As was found previously (Aickin et al., 1984), in normal ureteric tissue, removal of 
extracellular Na+ had no effect on Ca2+ and force in guinea pig ureter smooth muscle 
(Figure 5.3 A). However, if the tissue was pretreated with Na+-K+ pump inhibitor 
ouabain (10'4M) for 1 hour which enabled ureter to gain Na+ (Aickin et al., 1984). 
Na+-loaded ureter when exposed to Na+-free solution for a short time (40s) produced a 
rapid rise in Ca2+ and force activated by the reversed mode of Na+-Ca2+ exchanger 
(Figure 5.3).
Application of PKC activator PDBu for 10 minutes had little effect on the amplitude 
of Ca2+ and force induced by Na+-free solution (Figure 5.3). The extracted trace 
Figure 5.3 B from the original trace Figure 5.3 A clearly shows that PDBu had little 
effect on the amplitude of force which was only increased 1.04 ± 0.04 times (n=9) 
(P>0.05) compared to control (Figure 5.4 A). It also produced little changes in the 
amplitude of Ca2+ transient (1.02 ± 0.04 times, n=9) (P>0.05) (Figure 5.4 B).
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Statistical analysis of the data suggests that Na+-Ca2+ exchanger in at least Ca2 entry 
mode is virtually insensitive to PKC activation. These data suggest prolongation of 
the duration of Ca2+ transient associated with the action potential produced by PKC 
activator PDBu does not involve Na+-Ca2+ exchanger.
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2+Figure 5.3 The effect o f PDBu on Ca transients and phasic contraction evoked by 
Na+-free solution in Na+ -loaded guinea pig ureter smooth muscle. A- Original trace
2+  +  •showing changes in [Ca ]i and force induced by Na -free solution (tris substitution)
applied for 40s before and after treatment with ouabain (10-4 M) and their modulation
2+by PDBu. B- Extracted data from A showing the individual Ca transients and force 
induced by Na+-free solution and Na -free solution with PDBu in the presence of 
ouabain.
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Figure 5.4 Mean values of amplitude of force (A) and Ca transients (B) induced by 
Na+-ffee solution (Control) and Na+-ffee solution with PDBu for 10 minutes and 
expressed as percentage of control. Note lack o f significant effect o f PKC activation 
on the activity o f Na+- Ca2+ exchanger in “Ca2 -entry” mode.
PDBu
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5.4 Discussion
Either removal of external Na+ or application of Ca2+ antagonists (at low 
concentration) can lead to significant decrease in duration of the plateau component of 
the action potential in guinea pig ureter smooth muscle (Shuba, 1977(2)). Therefore, 
both extracellular Na+ and Ca2+ are essential for maintaining the plateau component of 
action potential. Ca2+ can enter into the smooth muscle cells via L-type Ca“+ channel. 
However, it is not known how extracellular Na+ is affecting parameters of the action 
potential in ureter smooth muscle. Since there is no voltage-dependent Na+ channel 
found in this tissue, one of the possible assumptions is that both Ca2+ and Na+ 
contribute to the generation of the plateau component of action potential via a 
common channel (Shuba, 1977(2)). Papaverine was shown to specifically block the 
common channel for both Ca2+ and Na+ (Brading et al., 1983). Since all the inward 
current can be abolished by Ca2+ channel blockers, another possible explanation is the 
findings of an extracellular Na+ dependent late inward current which can be activated 
by elevation of [Ca2+]i (Imaizumi et al., 1989). The Na+-Ca2+ exchanger might be the 
possible explanation for generating the late inward current. Meanwhile, Aaronson et 
al. also reported that Na+-Ca2+ exchanger can modulate [Ca2+]i in physiological 
normal conditions (Aaronson et al., 1989). Nifedipine-resistant slow rises in [Ca2+]i 
elicited by depolarization can be potentiated by reduction of the [Na+]0 or elevation of 
[Ca2+]0 have been reported for voltage clamped ureteric myocytes (Aaronson et al., 
1989). Other possibility which includes inactivation of Ca2+ current by extracellular
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Na+ as was found in cardiac muscle can not be excluded (Fedida et al., 1987).
Previous work showed the evidence that Na+-K+ pump can be fully blocked by 
ouabain at a concentration of 10'4 M (Aickin, 1987(2)). After application of ouabain, 
either removal of extracellular Na+ or elevation of extracellular Ca2+ can contribute to 
the extrusion of Na+ in Na+-loaded ureter producing a contraction (Aickin, 1987(1); 
Lamont et al., 1998).
Na+-Ca2+ exchanger can be studied by alteration of the Na+ gradient across the cell 
membrane. This can be done either by removal of external Na+ or an increase in 
internal Na+ concentrations. In this work, the tissue with normal [Na+]j failed to 
contract in response to Na+-ffee solution. However, after inhibition of Na+-K+ pump 
with ouabain, [Na+]i rised from the resting level at about lOmM to a level of 
18-25mM reported by Lamont et al. (1998) and to a level of 20.6 mM reported by 
Aickin (Aickin, 1987(2)). Thus, Na+-Ca2+ exchanger is suggested to be involved in 
this process to help maintain the low [Na+]i level in the absence of Na+-K+ pump 
activity. However, the tissue maintains a relatively high level of intracellular Na+ 
compared to control condition which can be rapidly lowered by a decrease in external 
Na+ or an increase in external Ca2+ by Na+-Ca2+ exchanger in reverse mode associated 
with entry of sufficient Ca2+ to initiate a contraction (Aickin et al., 1984). This 
contraction is insensitive to Ca2+ antagonists and is associated with the loss of 
intracellular Na+ (Aickin et al., 1984). PKC activator PDBu does not significantly
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increase the amplitude of Ca2 and force induced by Na+-ffee solution in Na+-loaded 
ureter, which suggests that PKC is not involved in the regulation of Na+-Ca2+ 
exchanger activity in its Ca2+ entry mode.
The amplitude of Ca2+ and force evoked by EFS was significantly decreased by 
removal of extracellular Na+. This is consistent with the previous findings that 
removal or replacement of extracellular Na+ abolished the duration of the plateau 
component of action potential, only the initial spike component was seen (Shuba, 
1977 (2); Brading et al., 1983; Imaizumi et al., 1989; Burdyga & Wray, 1999). PKC 
activator PDBu could still produce strong stimulant effect in Na+-free solution. This 
suggests that the stimulant effects on Ca2+ and force by PDBu may not be associated 
with the extracellular Na+ and not with the activity of Na+-Ca2+ exchanger in guinea 
pig ureter.
On the basis of the observations, the conclusion can be drawn that the influx of Na+ 
into the cells are important for excitation-contraction coupling mechanism in ureter 
smooth muscle, which is in general agreement with previous findings (Brading et al., 
1983; Shuba, 1977(2)). Moreover, the stimulant action of PDBu in Na+-free solution 
is not abolished. Thus these data and the lack of effects of PDBu on the activity of 
Na+-Ca2+ exchanger directly at least in Ca2+-entry mode strongly suggest that the 
Na+-Ca2+ exchanger or any other Na+-dependent mechanism are not targeted by PKC 
in the guinea pig ureter and thus can not explain possible mechanism of the stimulant
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action of PKC activation on duration of action potential and Ca transient.
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Role of PKC in stimulant action of agonists in the guinea pig
ureter smooth muscle
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Role of PKC in stimulant action of agonists in the guinea pig ureter 
smooth muscle
6.1 Introduction
In the guinea pig ureter smooth muscle, agonists such as carbachol and histamine 
produced stimulant action by increasing the duration of the plateau component of the 
action potential (Shuba, 1977(1); Burdyga & Wray, 1999).
Histamine, a biogenic amine involved in immune responses, acts directly on smooth 
muscles as a powerful stimulant agent. It may cause vasodilation, separation of 
endothelial cells and an increase in vascular permeability. Histamine or a related agent 
may play a physiological role in normal ureteric activity (Borgstedt et al., 1962). By 
using double sucrose-gap method, Shuba showed that histamine prolonged the 
duration of the plateau of the action potential and increased the amplitude and 
duration of the phasic contraction (Shuba, 1977(1)). Histamine depolarized the cell 
membrane and initiated spontaneous action potential. The amplitude of the plateau 
component was not changed and the spike amplitude and duration were unaffected. 
The changes caused by histamine were relatively easily reversible. Histamine was 
shown to cause PKC translocation from cytosol to cell membrane in smooth muscle 
cells (Langlands et al., 1992; Boterman et al., 2005; Jin et al., 2008). It was shown 
that histamine could activate latent pacemakers of the ureter's middle area (Kazarian
Chapter 6
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et al., 2003). Histamine exerts its function by binding to histamine receptors. There 
are four types of histamine receptors -  Hi, H2, H3 and H4, of which, Hi histamine 
receptor was found in most types of smooth muscle and endothelium.
Adrenergic stimulation also produced stimulant action in the guinea pig ureter smooth 
muscle by increasing the duration of the plateau component of the action potential 
(Shuba, 1977(1)). In some vascular smooth muslce, the phenylephrine increased 
contraction at constant intracellular free Ca2+ concentration which is thought due to 
activation of a Ca2+-independent isoform ofPKC (Collins et al., 1992). In human 
prostatic smooth muscle cells, phenylephrine can activate BKca channel because this 
type of smooth muscle requires higher concentration of phenylephrine for contraction 
(Kurokawa et al., 1998). It has also been shown that PKC is involved in 
phenylephrine-induced contraction in smooth muscle (Andrea & Walsh, 1992).
Therefore, the present study was undertaken to investigate the effect of exogenous 
agonists histamine and phenylephrine on force and Ca2+ evoked by EFS and to 
evaluate possible role ofPKC involved in the stimulant action of these agonists.
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6.2 Materials and Methods
Simultaneous measurement of calcium and Force
The simultaneous measurement of force and intracellular calcium were described in 
Chapter 2.
Krebs solution was prepared as described in Chapter 2. The tissue was continuously 
perfused with Krebs, Krebs containing histamine(lpM), phenylephrine( 1 pM) and 
Ro320432 (5pM).
The ureter smooth muscle were stimulated electrically at interval of about 40 seconds 
to produce phasic contraction associate with Ca2+ transients by using Ag/AgCl 
electrodes placed in the bath with rectangular pulses (3-5V, 200ms).
Chemicals
All chemicals were purchased from Sigma (Dorset, UK), unless otherwise stated. 
Ro320432 was purchased from Calbiochem.
The stock solutions were prepared as following method: Ro320432 was dissolved in 
DMSO at a concentration of 5mM. Histamine was dissolved in water at a 
concentration of ImM. Phenylephrine was dissolved in water at a concentration of 
ImM. The stock solutions were diluted to the desired concentrations with Krebs 
solution before starting the experiment.
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Statistics
Data was analysed with t-test (paired or unimpaired); differences between means were 
assumed to be significant at P<0.05. All values represent mean ± s.e.m; n is the 
number of samples, each one from a different animal.
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6.3 Results
Effects of PKC inhibitor Ro320432 on calcium transients and phasic contractions 
evoked by EFS in the guinea pig ureter smooth muscle in the presence of 
histamine and phenylephrine.
To determine if PKC is involved in the stimulant action of histamine and 
phenylephrine in the guinea pig ureter smooth muscle, we have studied the effects of 
PKC inhibitor Ro320432 on the stimulant effects of either histamine or phenylephrine 
on the amplitude and duration of the Ca2+ transients and force evoked by EFS. The 
experiments were performed on 14 animals for each of the agonists and presented in 
Figures 6.1 and 6.2, respectively. Figure 6.1 shows the representative trace of 
simultaneous recording of phasic contraction and Ca2+ transients in the guinea pig 
ureter evoked by EFS in control condition, in the presence of histamine (lpM) and in 
the presence of histamine (lpM) with Ro320432 (5pM). Figure 6.2 shows similar 
data for phenylephrine (lpM). From Figures 6.1 and 6.2, it can be seen that either of 
the agonists increased the amplitude of force evoked by EFS which was associated 
with an increase in the duration of the Ca2+ transient (Figure 6.1 B for histamine and 
Figure 6.2 B for phenylephrine). Treatment of the ureteric strips with PKC inhibitor 
Ro320432 for 20 minutes produced substantial decrease in the stimulant action of 
histamine (Figure 6.1) and phenylephrine (Figure 6.2) mainly on the duration of the 
Ca2+ transient and force. Therefore, the duration of the Ca2+ transient in the absence 
and presence of histamine was 0.75 ± 0.04 s and 1.38 ± 0.07 s, respectively (P<0.05).
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After treatment of Ro320432 it was reduced to 0.92 ± 0.04 s. The duration of the Ca2+ 
transient in control conditions, presence of phenylephrine and combined action of
phenylephrine and Ro320432 were 0.63 ± 0.05 s, 0.93 ± 0.12 s and 0.76 ± 0.02 s
2+
(P<0.05), respectively. Changes in the amplitude and the durations of force and Ca 
expressed as percentage of control during agonists stimulation in the absence and 
presence of Ro320432 are shown in Figures 6 .IB and 6.2B, respectively. These data 
suggest that PKC is only partly involved in the stimulant action of histamine and 
phenylephrine in the guinea pig ureter smooth muscle.
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Figurevó.l A-Individual traces of Ca2+ transients and force induced by histamine and histamine in 
the presence of Ro320432. B-Mean values of amplitude (a) and duration (b) of force and 
amplitude (c) and duration (d) of Ca transients induced by histamine and histamine in the 
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6.4 Discussion
In ureter smooth muscle, the agonists such as histamine and phenylephrine produce 
stimulant action which is similar to that of PDBu, i.e. all of them produce an increase 
in duration of the Ca2+ transient associated with the plateau component of the action 
potential (Shuba, 1977(1); Burdyga & Wray, 1999). Thus agonists and PDBu that can 
prolong the plateau phase will maintain the Ca2+ signal at its peak level for longer 
time which is associated with the increase in the amplitude of force (Shuba, 1977(1); 
Burdyga & Wray, 1999). In this study, agonists histamine and phenylephrine 
increased force and the duration of the [Ca2+]i signal measured at 50% of the peak 
Ca2+ transient which is due to the prolongation of the action potential. This is 
consistent with the findings of Shuba who showed that histamine has the stimulant 
effect on action potential and phasic contraction by using double sucrose-gap method 
(Shuba, 1977(1)). These stimulant effects of histamine and phenylephrine on Ca2+ and 
force in guinea pig ureter are similar to those of PDBu. In vascular smooth muscle, it 
was shown that application of either agonists such as histamine or PDBu could cause 
PKC translocation from cytosol to the plasma membrane. Therefore, it is important to 
know whether PKC plays an important role in the agonists induced modulation of 
contraction in the guinea pig ureter smooth muscle.
In smooth muscle, agonists can activate specific receptors on cell membrane. 
Histamine can bind to Hi_4-histamine receptors depend on which receptors are
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expressed in the tissues while phenylephrine binds to ai-adrenergic receptor therefore 
leading to a series of intracellular signal cascades in the smooth muscle cells. Many 
smooth muscle agonists such as angiotensin II, histamine and a-adrenergic receptor 
agonists act through receptors coupled to the following mechanism (Hoiting et al., 
1996; Challiss et al., 1992). When the agonists activate its receptor on the cell 
membrane, PLC is activated and leading to hydrolysis of PEP2 to formation of two 
intracellular messengers, IP3 and DAG. IP3 binds to its receptors on SR to trigger the 
Ca2+ release from SR in smooth muscle. In guinea pig ureter smooth muscle, IP3 
receptor is not found on SR but only RyR is expressed (Burdyga & Wray, 1999). IP3 
activity can be excluded in this tissue. Activation of agonists could increase the DAG 
production and directly activate PKC activity causing PKC translocation from cytosol 
to the plasma membrane (Langlands et al., 1992; Boterman et al., 2005; Jin et al., 
2008). In this study, PKC inhibitor Ro320432 could partly inhibit the stimulant action 
of both histamine and phenylephrine on Ca2+ and force which suggests that PKC is 
partly involved in the agonist dependent control of contraction in guinea pig ureter 
smooth muscle. The agonist-induced augmentation of contraction also includes other 
kinases or proteins such as Rho kinase as found in many other types of smooth muscle, 
e.g., gallbladder (Seyhan et al., 2005), vascular smooth muscle (Eto et al., 2001; Ratz 
et al., 2004) and myometrial smooth muscle (Kupittayanant et al., 2001). Activation 
of smooth muscle contraction by agonists such as phenylephrine was found to 
translocate RhoA from cytosol to membrane (Gong et al., 1997; Fujihara et al., 1997). 
PKC is playing a very different role in the agonists-induced contraction in smooth
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muscle. Activation of PKC is required for agonists-induced contraction in mouse 
aorta but not in corpus cavemosal smooth muscle (Jin et al., 2008). PKC is involved 
in the ai-adrenergic receptor meadiated contraction in rat tail artery (Sato et al., 2001). 
In guinea pig lung parenchymal strips, PKC participated in the Hi-receptor mediated 
contraction via regulation of Ca2+ infiilx (Leurs et al., 1989). It may be due to that in 
addition to PKC effect on the MLCP directly, it may have effect on other ion channels 
or mechanisms.
In conclusion, by using the specific PKC inhibitor Ro320432, we found direct 
evidence for the partial involvement of PKC in the agonists-induced augmentation of 
guinea pig ureter smooth muscle contraction by H-histamine receptor and 
ai-adrenergic receptor agonists.
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Chapter 7
Evidence that PKC is involved in Ca2+ sensitization in rat ureter smooth 
muscle
7.1 Introduction
Smooth muscle contraction is controlled by changes in intracellular [Ca2+]i. The contraction 
can be enhanced by increasing the sensitivity of contractile apparatus to [Ca2+]i (Kamishima 
et al., 1992).
The increased cytosolic free Ca2+ binds to calmodulin and activates the MLC20 
phsophorylation which results in smooth muscle contraction (Driska et al., 1981). High K+ 
stimulation is a relatively “simple’ mechanism of activation of smooth muscle via activation 
of voltage-dependent Ca2+ channels which leads to an increase in cytosolic free Ca2+ (Bolton 
et al., 1979; Ratz et al., 2004). Therefore, it has been used as an experimental model to study 
the effect of non-receptor activation of smooth muscle contraction.
Muscarinic receptor agonist carbachol could also produce smooth muscle contraction in Ca - 
dependent and Ca2+-independent way (Kamishima et al., 1992). It has been shown that 
carbachol could cause Ca2+ release from SR and contraction in rat ureter smooth muscle by 
activation of IICR mechanism (Burdyga et al., 1998). In guinea pig ileum, either PDBu or 
carbachol could cause PKC translocation from the cytoplasm in smooth muscle cells and lead 
to smooth muscle contraction (Poole et al., 2007). In rat bronchial smooth muscle, carbachol 
could depolarize cell membrane and activate voltage dependent Ca2+ channels (Kamishima et
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al., 1992). On the other hand, carbachol can induce the contraction by altering the [Ca2+]i 
sensitivity which is regulated primarily at the level of MLC20 phosphorylation by modulation 
of MLCP activity (Kitazawa et al., 1991; Kubota et al., 1992). Carbachol binding to G- 
protein coupled receptors activates PLC which leads to the breakdown of PIP2 leading to 
production of IP3 and DAG which activates PKC. PKC could phosphorylate CPI-17 which 
inhibits MLCP. Therefore PKC can increase MLC20 phosphorylation in a Ca2+-independent 
way in agonist induced contraction (Li et al., 1998; Hartshome et al., 1998; Eto et al., 2004). 
KC1 does not cause phosphorylation of CPI-17 in the tonic femoral artery or phasic vas 
deferens in the presence of a-adrenergic receptor blockade (Kitazawa et al., 2000, 2003). Rho 
A/ROCK was reported to contribute to modulation of MLCP and Ca2+ sensitization 
mechanism in smooth muscle including rat ureter (Shabir et a l, 2004; Rats et al., 2004). Rho 
kinase can also modulate CPI-17 activity (Somlyo AP et al., 2003; Ito et al., 2004).
In Chapter 3, we have described that in rat ureter, PKC is involved in modulation of phasic
contraction in a Ca2+-independent manner. To further study this effect we have used several
2+
experimental models. First, we have studied the effects of PKC activator PDBu on force-Ca 
relationship in rat ureter smooth muscle stimulated by high K+ depolarization. In these 
experiments the effects of PDBu on the amplitude of tonic contraction and its relaxation rate 
induced by Ca2+ free solution have been examined. Secondly, we have used PKC inhibitor 
Ro320432 to assess possible contribution of PKC to Ca2+ sensitization induced by carbachol. 
In this experiment, the effects of carbachol in Ca2+ free solution on Ca2+, MLC20 
phosphorylation and force in the absence and presence of PKC inhibitor have been 
investigated.
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7.2 Materials and Methods
Simultaneous measurement of calcium and tension
The simultaneous measurement of force and intracellular calcium were described in Chapter
2.
Krebs solution was prepared as described in Chapter 2. The tissue was continuously perfused 
with Krebs. High K+ solution was applied for 40 seconds. Carbachol was applied in Ca2+-ffee 
solution for 30 seconds.
Measurement of myosin light chain phosphorylation
The measurement of myosin phosphorylation was carried out after separation of the 
nonphosphorylated and phosphorylated forms of myosin light chain (MLC20) using 
urea/glycerol-polyacrylamide gel electrophoresis and quantified as detailed in Chapter 2.
Chemicals
All chemicals were purchased from Sigma (Dorset, UK), unless otherwise stated. PDBu was 
purchased from Calbiochem.
The stock solutions were prepared as following method: PDBu was dissolved in DMSO at a 
concentration of ImM. Ro320432 was dissolved in DMSO at a concentration of 5mM.
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Carbachol was made up in a stock solution of concentration lOmM. The stock solutions were 
diluted to the desired concentrations with Krebs solution before starting the experiment.
Statistics
Data was analyzed with t-test; differences between means were assumed to be significant at 
P<0.05. One-Way ANOVA test was applied to test the significant difference (P<0.05) 
between different groups. All values represent mean ± s.e.m; n is the number of samples, each 
one from a different animal.
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7.3 Results
7.3.1 The effect of PDBu and Ro320432 on force and Ca2+ evoked by EFS and high K+ in 
rat ureter smooth muscle
In this study, two experimental models have been used to study the effects of PKC activator 
PDBu and inhibitor Ro320432 on force and Ca2+ in rat ureter— phasic contraction evoked by 
EFS (described in chapter 3) and tonic contraction evoked by high K+ depolarization.
Figure 7.1 (detailed in chapter 3) shows in rat ureter, an increase in the amplitude of phasic 
contraction produced by PDBu was not associated with changes of the parameters of the Ca2+ 
transients. Relaxation phase of the phasic contraction was slowed down by PDBu with no 
change in the kinetics of the relaxation decay of the Ca transient.
High K+ solution was applied quickly for 40 seconds. The KCl-induced contraction 
consisting of initial phasic contraction followed by a sustained tonic component was 
produced. When tonic contraction reached steady state, the tissue was placed in Ca2+-ffee 
solution to induce relaxation in the absence and presence of PDBu.
From Figure 7.2, it can be clearly seen that the tonic component of high K+ induced 
contraction was enhanced by PDBu and this stimulant effect can be abolished by Ro320432. 
The amplitude of tonic contractions in the presence of PDBu was 1.2 ± 0.05 times compared 
to control (n=9) (P<0.05) and Ro320432 brought it back to the control level. The activation 
of tonic force seen in the presence of PDBu was not associated with an increase in the 
sustained component of calcium transients (Figure 7.2 A and B).
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The effect of PKC on relaxation phase of KC1 contraction has been studied. Figure 7.3A 
shows the superimposed traces of normalized force and Ca2+ induced by high K+ in rat ureter 
in the absence and presence of 0.1 pM PDBu. Figure 7.3 B shows superimposed traces of 
relaxation phase of both force and Ca2+ transient induced by Ca2+ free solution which shows 
that in rat ureter relaxation of force was slowed by PDBu compared to control with no change 
in the kinetics of the relaxation of the Ca2+ transient (Figure 7.3 B and C).
Half-time of relaxation of force in control conditions was 16.3 ± 2.3 s (n=10) and in the 
presence of PDBu was 23 ± 2 s (n=10) (P<0.05). The data obtained strongly suggest 
involvement of PKC in Ca2+ sensitization in rat ureter smooth muscle as an increase in the 
amplitude of tonic contraction produced by PDBu was Ca2+ independent. In addition, marked 
decrease in the relaxation phase of the tonic contraction induced by Ca2 ' -free solution seen in 
the presence of PDBu with no change in the kinetics of the relaxation of Ca2+ transient also 
suggest Ca2+ independent effect of PKC on rat ureter contractility.
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Figure 7.1 The effect o f PKC activator PDBu on calcium and phasic contractions evoked by 
EFS in rat ureter smooth muscle. A- Individual Ca transients and phasic contractions o f rat
ureter smooth muscle recorded in the presence and absence o f PDBu; B- Superimposed
2+
records from A; C- Superimposed relaxation phase o f force and Ca transient from B. In this 
figure, records in red are obtained in the presence o f PDBu; Black are controls. Note the
relaxation phase of rat ureter phasic contraction is slowed down by PDBu with no change of
„  2+
Ca .
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Figure 7.2 The effect of PKC activator PDBu and PKC inhibitor Ro320432 on force and 
calcium evoked by high K+ depolarization in rat ureter. A- Force and Ca evoked by high K 
depolarization in control, in the presence o f PDBu and PDBu with Ro320432; B- Mean 
values o f amplitude o f tonic component (a) and Ca transients (b) induced by high K 
depolarization in the absence and presence o f PDBu expressed as percentage o f control.
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Figure 7.3 The effect o f PDBu on the kinetics of force and calcium evoked by high K 
depolarization in the rat ureter. A- Superimposed records o f force and Ca transient induced 
by high K+ depolarization in rat ureter smooth muscle in the absence and presence o f PDBu. 
B- Superimposed relaxation phase o f force and Ca transient from A. In Figure A and B, 
records in red are obtained in the presence o f PDBu; Black are controls. C-Mean values of 
half-time relaxation of force (a) and Ca 2+ transients (b) induced by high K+ depolarization in 
the absence and presence of PDBu and expressed as percentage o f control.
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7.3.2 The effect of PKC inhibitor Ro320432 on the force, Ca2+ transients and myosin 
light chain phosphorylation evoked by carbachol in Ca2+-free solution
In this study, the role of PKC in agonist induced contraction in rat ureter has been 
investigated.
The preparation was first stimulated by high K+ solution for 40 seconds to maximally load 
the SR with Ca2+. Then, it was placed in calcium free solution for 80 seconds, and stimulated 
with lOOpM carbachol for 30 seconds to induce Ca2+ release from SR. The experiments were 
performed in control condition and in the presence of Ro320432 (10 minutes treatment). 
Figure 7.4A shows that carbachol could induce a transient Ca2+ release from the SR leading 
to a transient contraction. When PKC was inhibited by Ro320432 the amplitude of force 
induced by carbachol was decreased to 80 ± 3% of control which was not associated with any 
change in Ca2+ transients (Figure 7.4 B) (P<0.05).
The relaxation rate of force induced by carbachol in the presence of Ro320432 was 
significantly increased while that of the Ca2+ transient remained virtually unchanged (Figure 
7.5). The ti/2 for relaxation of force in control conditions was 13.6 ± 1 s (n=10) and in the 
presence of Ro320432 was 7 ± 0.5 s (n=10) (Figure 7.5 C) (P<0.05). From the phase-plane 
plots shown in Figure 7.5 B, it can be seen that Ro320432 did not produce any significant 
effect on force-Ca2+ relationship for the rising phase of contraction compared to control. In 
contrast, the force-Ca2+ relationship for the relaxation phase in the presence of Ro320432 
significantly shifted to the right which indicated that PKC inhibition produced a Ca2+- 
independent acceleration of relaxation of force induced by carbachol in rat ureter. Figure 7.5 
B shows that the amplitude of force at any given [Ca2+]i in the presence of Ro320432 was
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less compared to control condition. In addition, it can be seen that there is a delay between 
the rise in [Ca2+]i and the generation of force, i.e. Ca2+ transient peaked before force reached 
its peak value. Again, in the presence of Ro320432 force peaked earlier and began to 
prematurely relax despite Ca2+ transient remained the same as under control conditions 
(Figure 7.5 A and B).
The enhanced relaxation of the carbachol induced contraction with no change in the kinetics 
of the Ca2+ transient suggests that in the presence of PKC inhibition a calcium-desensitization 
of the contractile machinery to Ca2+ is taking place via activation of MCLP leading to a faster 
dephosphorylation of MLC20 in a Ca2+-independent way.
Therefore, in the next set of experiment, the effect of Ro320432 on the myosin light chain 
phosphorylation levels at different time of development of carbachol induced contraction in 
the absence and presence of Ro320432 was studied.
The ureteric strips were fast frozen at different times during the rising and relaxation phase of 
the force (Figure 7.6 B). The myosin light chain phosphorylation level at each point has been 
measured. Figure 7.6 A shows the representative chemilumigrams of western blots measured 
during the rising and relaxation phase of carbachol induced contracture (shown by arrows in 
Figure 7.6 B) in the absence and presence of Ro320432. Figure 7.6 B shows the 
superimposed scatter plots of force (top panel) and myosin light chain phosphorylation 
(bottom panel) under control condition and in the presence of 5pM Ro320432 measured at 
different points during the development of carbachol induced contraction in rat ureter. In the 
absence of carbachol in Ca2+-free solution there is no detectable level of myosin light chain
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phosphorylation. Figure 7.6 B shows that there is no difference in myosin light chain 
phosphorylation level during the rising phase of the force between control and Ro320432 
treated preparation. During carbachol stimulation, myosin light chain phosphorylation 
quickly reached the maximum level and started to decline to the baseline level. Force was 
lagging behind MLC20 phosphorylation and reached its peak at a time when myosin light 
chain phosphorylation already declined to about 60-70% of its maximal level. Figure 7.6B 
shows that force-MLC2o phosphorylation relationship during the rising phase of carbachol 
induced contracture obtained in the presence of Ro320432 was virtually the same as that seen 
under control conditions. In marked contrast, force-MLC2o phosphorylation relationship 
during the relaxation phase was shifted to the left. Since there was no change in the kinetics 
of the Ca2+ transients induced by carbachol in the absence and presence of PKC inhibition 
(Figure 7.5 A, bottom trace). These data suggest that force produced by carbachol stimulation 
in Ca2+ free solution is generated in Ca2+-dependent way via activation of Ca2+/Calmodulin 
dependent MLCK and Ca2+ independent way, i.e. Ca2+ sensitization via decreasing the 
activity of MLCP responsible for dephosphorylation and relaxation of the force.
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Figure 7.4 The effect o f Ro320432 on the force and calcium evoked by carbachol in the rat
2+
ureter. A- Force and Ca transient evoked by carbachol in the absence and presence of
2+
Ro320432 in the rat ureter. B- Mean values o f amplitude o f force (a) and Ca. transients (b) 
induced by carbachol in the absence and presence o f Ro320432 expressed as percentage of 
control.
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Figure 7.5 The effect of Ro320432 on force and calcium evoked by carbachol in the rat
2+
ureter. A- Superimposed records o f force and Ca transient evoked by carbachol in the 
absence (black) and presence (red) o f Ro320432 in the rat ureter. B- Phase-plane plot
showing force-Ca relationship during the development o f carbachol induced contraction. C-
2+
Mean values o f half-time relaxation o f force (a) and Ca transients (b) induced by carbachol 
in the absence and presence o f Ro320432 and expressed as percentage o f control.
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Figure 7.6 Effect o f Ro320432 on force and myosin light chain phosphorylation evoked by 
carbachol stimulation in rat ureter. A-Representative western blots showing phosphorylated 
and non-phosphorylated bands o f MLC20 for the relevant points 1 and 2 shown by arrows in 
B. B- Superimposed scatter plots o f force (top trace) and MLC20 phosphorylation (bottom 
trace) o f control (black circles), and in the presence o f Ro320432 (red circles) induced by 
carbachol (The data from Figure B were obtained with help o f Dr L. Borisova and Dr T. 
Burdyga).
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7.4 Discussion
In smooth muscle, the increased intracellular Ca2+ binds to calmodulin and this complex 
activates the myosin light chain kinase which phosphorylates the myosin light chain at Seri9 
(Hartshome et al., 1987). It is required for activation of the actin-activated myosin ATPase of 
smooth muscle contraction (Hartshome et al., 1981). The level of MLC20 phosphorylation 
can also be modulated in Ca2+ independent way via modulation of myosin light chain 
phosphatase activity. Several kinases have been shown to contribute to modulation of the 
activity of MLCP in smooth muscle. PKC has been suggested to play an important role in 
modulating the activity of MLCP (Somlyo & Somlyo, 1994). Activation of PKC can inhibit 
MLCP and therefore leads to an increase in smooth muscle contraction.
To examine possible role of PKC in control of Ca2+ sensitivity in rat ureter smooth muscle 
contraction, we have investigated the effects of PKC activation and inhibition on force-Ca2+ 
relationship using different modes of stimulation such as EFS, high K+ depolarization and 
carbachol.
Our data suggest that in rat ureter smooth muscle, the effect of PKC activation appears to 
affect force by sensitizing contractile machinery to Ca2+ irrespective of the modes of 
stimulation. When ureter smooth muscle was treated with 0.1 pM PDBu, the amplitude of the 
phasic contraction induced by EFS and amplitude of sustained component of high K+ induced 
contractions were increased with no change in [Ca2+]i. Measurement of half-time of 
relaxation phase of phasic contraction and tonic contraction both shows that PDBu could 
slow down the relaxation without change of intracellular Ca2+ level. These findings are 
similar to those obtained in other types of smooth muscle in which activation of PKC by
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agonists activate force without a corresponding change in intracellular Ca2+ (Andrea et al., 
1992). Therefore, we could conclude that PKC regulates rat ureter smooth muscle contraction 
in Ca2+-independent way and is likely to be involved in Ca2+-sensitization mechanism by 
affecting the activity of MLCP.
PKC has been shown to play an important role in control of contraction by affecting MLCP - 
the process called Ca2+ sensitization in several types of smooth muscle (Kitazawa et al., 1999; 
Takuwa, 1996; Shirao et al., 2002). It was shown that activation of PKC phosphorylated CPI- 
17 at Thr38 thus increasing its inhibitory potency of MLCP over 1000 fold (Eto et al., 1997; 
Hayashi et al., 2001). Therefore activation of PKC could lead to an increase in force 
generated in smooth muscle without change of intracellular Ca .
In tonic smooth muscles, agonists binding to G-protein coupled receptor leads to hydrolysis 
of PIP2 which then leads to formation of IP3 and DAG. IP3 binds to IP3 receptor causing Ca“+ 
release from SR and thereby producing an initial intracellular calcium transient accompanied 
by force generation (Merkel et al., 1991; Somlyo & Somlyo et al., 1994).
In rat ureter, PKC is involved in agonist induced modulation of contraction in Ca - 
independent way. Application of PKC inhibitor Ro320432 could inhibit the cabachol induced 
contraction while the level of Ca2+ remained unaltered. Furthermore, Ro320432 increased the 
rate of relaxation of carbachol induced contraction with no change in the kinetics of Ca2+ 
transients which suggests that PKC is involved in the agonist induced contraction in Ca2+- 
independent way.
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Many studies performed on tonic smooth muscles suggested that activation of PKC could 
inhibit the MLCP activity thereby increasing the phosphorylation level of MLC20 (Budzyn et 
al., 2006). In case of carbachol stimulation in rat ureter, myosin light chain phosphorylation 
level can be directly correlated with force because Ca2+ signal is not altered between control 
and Ro320432 treated preparation. From the phase-plane plot, it can be clearly seen that 
force-Ca2+ relationship for the preparation treated with Ro320432 during relaxation phase is 
shifted to the higher level of [Ca2+]i suggesting desensitization of the contractile activity to 
Ca2+. These data are in good agreement with a left shift of force-MLC2o phosphorylation 
relationship seen in the presence of Ro320432 during carbachol stimulation. The decreased 
amount of force generated in the presence of Ro320432 is due to the decreased myosin 
phosphorylation level. The acceleration of relaxation of force produced by Ro320432 is 
accompanied by the acceleration of dephosphorylation of the myosin light chain. This 
suggests that inhibition of force is due to an increased activity of MLCP. Inhibition of PKC 
increases MLCP activity leading to acceleration of dephosphorylation of myosin light chain 
during the relaxation phase of agonist-induced contraction. Collectively, the data obtained 
strongly suggest that the main mechanism underlying direct stimulant action of PKC by 
PDBu involves Ca2+-independent sensitization of contractile machinery and that this 
mechanism is partly involved in control of the stimulant action of agonists in rat ureter 
smooth muscle.
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Chapter 8 
Summary
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Chapter 8 
Summary
The main aim of the present work was to investigate role of PKC in control of 
excitation-contraction coupling in the guinea pig and rat ureter smooth muscle. The 
main finding of this study was that PKC was expressed and functionally important in 
control of contraction in the ureter of both species. However, expression, distribution 
and the mechanisms of stimulant action of PKC activation on ureter smooth muscle 
were species dependent.
PKC activator PDBu and inhibitor Ro320432 were used to investigate the functional 
role of PKC in control of phasic contraction in the guinea pig and rat ureter smooth 
muscle. Application of 0.1 pM PDBu produced a significant increase in the amplitude 
and duration of phasic contraction which was accompanied by an increase in the 
duration of the Ca2+ transient in guinea pig ureter while in rat ureter an increase in the 
amplitude of phasic contraction by PDBu was Ca2+ independent. PKC specific 
inhibitor Ro320432 at concentration of 5pM could fully reverse the stimulant effects 
of PDBu in both guinea pig and rat ureter smooth muscle. PDBu prolonged the 
relaxation time of the phasic contraction in rat but not in guinea pig ureter and it was 
not associated with any change in the kinetics of the Ca2+ transient. Overall, we found 
that PKC was involved in regulation of phasic contraction in a Ca2+-dependent way in 
the guinea pig and in a Ca2+-independent way in the rat ureter smooth muscle.
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The different role of PKC involved in modulation o f intracellular Ca2+ in two species 
might be due to the different expression and distribution patterns of various PKC 
isoforms. In the guinea pig ureter smooth muscle PKC a, p and 5 are expressed. In 
contrast, PKC a is present in rat ureter smooth muscle.
8.1 Mechanism of the stimulant action of PKC activation in the guinea pig ureter
Early electrophysiological studies demonstrated that action potential in the guinea pig 
ureter smooth muscle consists o f the spike and plateau component (Branding et al., 
1983; Burdyga & Wray, 1999). Patch clamp studies revealed that there are two major 
ionic currents responsible for generating the complex action potential in the guinea 
pig ureter smooth muscle: inward Ca2+ current and outward K+ current. Ca2+ current is 
produced by activation of L-type voltage gated Ca2+ channels and outward K+ current 
by large conductance K+ channels (BKca) (Lang, 1989; Imaizumi et al., 1989). 
Recently it was shown that BKca channels in the guinea pig ureter were activated by 
Ca2+ sparks (Burdyga & Wray, 2005).
8.2 Functional role of PKC in guinea pig ureter smooth muscle contraction
We have found that in guinea pig ureter smooth muscle activation o f PKC by PDBu 
prolonged the duration of the plateau component o f the action potential. This can be 
achieved by either activation of L-type Ca2+ channels or direct or indirect (via 
inhibition o f Ca2+ sparks) inhibition of BKca channels.
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8.2.1 Evidence that Ca2+ sparks/STOCs coupling mechanism is not involved in 
the stimulant action of PKC
Ca2+ sparks/STOCs coupling mechanism plays a very important role in setting the 
refractory period and control of the duration of the action potential in guinea pig 
ureter smooth muscle (Burdyge & Wray, 2005; Borisova et al., 2007). Inhibition of 
Ca2+ sparks or their target BKca channel by TEA prolonged the duration of the action 
potential (Burdyga et al., 1995; Borisova et al., 2007) which is associated with an 
increase in the duration of the Ca2+ transient leading to an increase in the amplitude 
and duration of force (Burdyga & Wray, 1999). In the present study, we have found 
that in guinea pig ureter smooth muscle PDBu produced marked increase in the 
amplitude and duration of force accompanied by an increase in the duration of the 
Ca2+ transient under experimental conditions when the SR function was fully blocked 
by CPA leading to inhibition of Ca2+ sparks or when BKca channels were blocked by 
TEA. In fact, the stimulant action of PDBu under these experimental conditions was 
increased. Therefore, the stimulant action of activation of PKC on action potential is 
not due to inhibition of Ca2+ sparks/STOCs coupling mechanism in the guinea pig 
ureter smooth muscle.
In agreement with these data we have also found that PKC activator PDBu actually 
increased the frequency of spontaneous Ca2+ sparks therefore could be expected to 
activate the Ca2+ sparks/STOCs coupling mechanism in the guinea pig ureter smooth 
muscle. If the effect of PKC on Ca2+ sparks/STOCs coupling mechanism was the only
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mechanism involved in regulation of guinea pig ureter smooth muscle contraction, the 
duration of the plateau component of the action potential could be decreased by PKC 
activation. However, our data clearly show that activation of PKC increased the 
duration of action potential and that it is not involved in inhibition of Ca 
sparks/STOCs coupling mechanism.
8.2.2 Is Na+-Ca2+ exchanger involved?
It was shown that both extracellular Na+ and Ca2+ contributed to the generation of the 
plateau component of the action potential in the guinea pig ureter smooth muscle 
(Shuba, 1977(2)). Removal of either extracellular Na+ or Ca2+ abolished plateau 
component of the action potential. There is no voltage-dependent Na+ channel in 
ureter smooth muscle and it was suggested that Na+-Ca2+ exchanger might contribute 
to this effect (Kuriyama et al., 1967; Shuba, 1977(2); Aaronson & Benham, 1989; Sui 
et al., 1997). Removal of extracellular Na+ caused significant decrease in the 
amplitude and duration of force associated with Ca2+ transients which is due to the 
abolishment of the plateau component of action potential as was found earlier (Shuba, 
1977(2); Brading et al., 1983; Imaizumi et al., 1989; Burdyga et al., 1999). Our data 
clearly show that in Na+-free solution PDBu still produced strong stimulant effect on 
phasic contraction and intracellular Ca2+. These data suggest that the stimulant effects 
of PDBu on Ca2+ and force are not associated with the targeting Na+-dependent 
mechanism.
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In agreement with these suggestions we also report lack of any effect of PDBu on 
Ca2+ and force induced by Na+-Ca2+ exchanger in Ca2+-entry mode in Na+-loaded 
ureter using protocols designed by Dr. T. Burdyga and his colleagues (Aickin et al., 
1984; Burdyga & Magura, 1987; Lamont et al., 1999). Therefore, the data obtained 
suggested that the Na+-Ca2+ exchanger or any other Na+-dependent mechanisms 
controlling the duration of the plateau component of the action potential are not 
involved in the stimulant action of PDBu on the action potential in the guinea pig 
ureter smooth muscle.
8.2.3 PKC and L-type Ca2+ channel
One could suggest that the stimulant action of PKC activation in the guinea pig ureter 
smooth muscle could involve modulation of voltage gated L-type Ca2+ channels. 
Preliminary experiments performed with help of Dr T. Burdyga using path clamp 
technique showed that PDBu increased the amplitude of the inward Ca2+ current (data 
not shown). However, more systemic studies were precluded by lack of time.
8.2.4 Is PKC involved in agonist effects?
PKC is involved in the stimulant action of agonists in different types of smooth 
muscle (Langlands et al., 1992; Collins et al., 1992; Boterman et al., 2005; Jin et al., 
2008). In the guinea pig ureter smooth muscle, histamine and phenylephrine have 
been shown to have stimulant effect on force via prolongation of the plateau 
component of the action potential (Shuba, 1977(1)). Using PKC inhibitor Ro320432
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in concentration which fully reversed stimulant action of PDBu we have found that 
stimulant action of either histamine or phenylephrine was only partly inhibited by 
PKC inhibitor. It suggests these agonists in addition to PKC also activate some other 
mechanisms which contribute to their stimulant action. PKA, Rho-kinase and other 
likely kinases could also be involved. However, possible role of the other kinases 
involved in the stimulant action of agonists in the guinea pig ureter smooth muscle 
was outside scope of this project.
8.3 PKC and rat ureter smooth muscle
In contrast to the guinea pig ureter, in rat ureter smooth muscle, activation of PKC by 
PDBu produced stimulant effect on force without affecting parameters of the Ca 
transients.
Our data strongly suggest that the main mechanism involved in the stimulant action of 
PDBu in rat ureter smooth muscle involves Ca2+ sensitization of the contractile 
machinery to Ca2+. Ca2+ sensitization was discovered in a number of smooth muscles 
and both PKC and Rho-kinase were shown to be involved (Somlyo & Somlyo, 1994; 
Kitazawa et al., 2000; 2003; Sakai et al., 2007; Mizuno et al., 2008). Both kinases 
were shown to inhibit myosin light chain phosphatase and thus producing additional 
increase in the level of myosin light chain phosphorylation and force at a constant 
level of [Ca2+]i (Kitazawa et al., 2000, 2003; Eto et al., 2004; Shabir et al., 2004; Ratz 
et al., 2004;Sakai et al., 2007). The fact that relaxation of phasic or tonic contraction
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by PDBu with no change in the kinetics of Ca2+ transients as well as potentiation of 
tonic component of high K+ contracture at the same [Ca2+]-, strongly suggests that 
PKC also potentiates force in rat ureter smooth muscle via Ca2+ sensitization 
mechanism.
Our data also indicate that PKC is involved in Ca2+ independent stimulant action of 
carbachol. Indeed, inhibition of PKC by Ro320432 markedly decreased the amplitude 
and accelerated the relaxation of carbachol induced contracture which correlated well 
with an increase in the rate of myosin light chain dephosphorylation in rat ureter 
smooth muscle. These changes in force and myosin light chain phosphorylation were 
observed with no change in the parameters of the Ca2+ transient associated with Ca2+ 
release from the SR. Our data suggest that carbachol binding to its receptor results in 
production of IP3 which activates Ca2+ release from the SR. Ca2+ binds to calmodulin 
and activates Ca2+/calmodulin dependent myosin light chain kinase which 
phosphorylates myosin light chains triggering cross bridge cycling leading to 
contraction. DAG activates PKC which inhibits activity of MLCP and this results in 
further increase in the level of myosin light chain phosphorylation at the same level of 
[Ca2+]i leading to additional increase in the contractile response, i.e. Ca2+ sensitization 
pathway. CPI-17 can be phosphorylated by PKC and increase its strong inhibitory 
effect on MLCP. The inhibitory potency of the phosphorylated form of CPI-17 can be 
increased more than 1,000 times by PKC activation (Eto et al., 1997; Hayashi et al., 
2001) .
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Our data clearly indicate that guinea pig and rat ureter express different isoforms of 
PKC and this could be one of the possible reasons of the species dependent effects 
observed. Guinea pig predominantly expressed PKC (3 and 8  while rat ureter 
predominantly expressed PKC a. Whether this difference in PKC expression can 
explain the difference in the stimulant action of PKC activation in ureter smooth 
muscle requires additional experiments by using other experiment approaches.
8.4 Future work
To investigate the mechanism of the stimulant action of PKC in guinea pig ureter, the 
effects of PKC activation on the ionic currents in voltage clamped ureteric myocites 
should be investigated by using the whole cell voltage clamp technique. Specific 
inhibitors of different PKC isoforms or RNAi could be used to identify functional role 
of different PKC isoforms in the ureter of both species. Expression and functional role 
of PKC in mice ureter could be investigated which would allow to use PKC KO mice 
as experimental models. In rat ureter phosphorylation of MYPT1 by PKC via CPI-17 
should be investigated to fully understand the mechanism of Ca2+ sensitization.
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Conclusions
1. Expression and functional role of PKC in the guinea pig and rat ureter smooth 
muscle have been studied.
2. In the guinea pig ureter three PKC isoforms a, P and 8  have been detected. PKC 
a was present in the smooth muscle but was more abundant in urothelium; PKC P 
was present in both smooth muscle and urothelium. PKC 5 was a dominant 
isoform expressed in the guinea pig ureter and was detected only in the smooth 
muscle.
3. In the rat ureter only two PKC isoforms a and p have been detected. PKC a was 
present in both smooth muscle and urothelium; PKC p was detected only in 
urothelium.
4. Direct activation of PKC by PDBu produced stimulant action on ureter smooth 
muscle of both species. However in the guinea pig ureter it was associated with an
increase in the duration of the Ca2+ transient which was correlated with an increase
2+
in the duration of the plateau component of the action potential. Neither Ca 
sparks/STOCs coupling mechanism nor Na+-Ca2+ exchanger was involved.
5. In the rat ureter smooth muscle direct activation of PKC by PDBu produced an 
increase in the amplitude of phasic contractions with no change in parameters of 
the Ca2+ transient suggesting that Ca2+ sensitization mechanism is the main 
mechanism.
6 . PKC inhibitor Ro320432 fully reversed stimulant action of PDBu in the ureter 
smooth muscle of both species and significantly decreased the stimulant action of 
agonists.
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7. The data obtained suggest that in the guinea pig ureter smooth muscle stimulant 
action of PKC on the duration of action potential is likely to be caused by 
stimulation of the inward Ca2+ current via L-type Ca2+ channels.
8 . In the rat ureter Ca2+ sensitization associated with inhibition of MLCP is the 
major mechanism underlying the stimulant action of PKC activation on the 
contractile activity.
9. In the guinea pig ureter, histamine and phenylephrine produced stimulant action 
by increasing the duration of the Ca2+ transient similar to PDBu. PKC inhibitor 
Ro320432 partly reduced the stimulant action of these agonists which suggests 
involvement of PKC.
10. In the rat ureter stimulant action of carbachol involved Ca2+ sensitization 
mechanism via inhibition of MLCP. PKC partly contribuid to this stimulant effect.
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